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Impairment of the atrioventricular electrical conduction (AV-block) is a major cause for 
the implantation of an electronic pacemaker device. Even though this is the standard 
treatment today, it has its disadvantages. One major problem is the implementation of 
long-term pacing therapy in pediatric patients owing to the restrictions imposed by a 
child’s small size and their inevitable growth. Thus there is a genuine need for 
innovative therapies especially for children with cardiac rhythm disorders. 
The aim of the Biopacer project is to develop an autologous conductive tissue 
device that will serve as an electrical conduit between the upper and lower chambers of 
the heart. The idea is to use pediatric cardiomyocytes together with a fibrin-based 
scaffold to produce a tissue construct that is completely autologous and has the ability to 
grow with the patient. Mimicking the complexity and highly organized structure of 
native cardiac tissue sets significant challenges for the engineering process. To address 
this challenge, bottom-up tissue engineering, in which structural components of 
different cell types with high-degree organization are fabricated separately and later 
assembled together, was applied. The aim of this thesis was to utilize different 
microfabrication techniques for the realization of the fibrin scaffold with different cell 
types to fabricate building blocks for the assembly of a conductive tissue device with a 
controllable, spatially organized tissue microarchitecture.  
Two methods, micromolding in capillaries (MIMIC) and microfabrication of fibrin 
fibers by extrusion, were established and exploited in the fabrication of cell-seeded 3D 
fibrin tissue modules. Using the MIMIC technique, cells were spatially confined into a 
3D fibrin gel structure and they were shown to align longitudinally in small diameter 
fibrin gels. In extruded fibrin fibers, endothelial cells were demonstrated to coalesce and 
bundle the surrounding fibrin into a core around which they arranged themselves 
resembling the phenomenon of tubulogenesis. The organization of these microfabricated 
tissue modules together to create a conductive tissue device consisting of separate 
functional units (e.g. aligned cardiomyocytes, vasculature, extracellular matrix) was 
additionally displayed. This way, all the structural components of native cardiac tissue 
are accounted for and highly organized in the engineered construct. 
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Sydämen johtoratajärjestelmän häiriö eteisten ja kammioiden välillä on yleisin syy sy-
dämen tahdistimen asentamiselle. Vaikka tahdistinhoito on hyvin yleinen ja luotettava 
hoitomuoto tänä päivänä, pitkäaikainen hoito erityisesti lapsipotilaiden keskuudessa on 
ongelmallista. Merkittävänä haasteena lasten tahdistinhoidossa on potilaan pieni koko ja 
lapsen väistämätön kasvu. Täten on aito tarve kehittää innovatiivisia hoitomuotoja sy-
dämen rytmihäiriöistä kärsiville lapsille.  
Biopacer projektin tavoitteena on kehittää autologinen kudosimplantti, joka toimii 
sähköimpulssien johtokanavana sydämen eteisten ja kammioiden välillä. Tarkoituksena 
on eristää sydänlihassoluja lapsipotilaan kudosnäytteestä ja käyttää niitä yhdessä fib-
riinipohjaisen skaffoldin kanssa valmistamaan täysin autologinen kudosimplantti, jolla 
on kyky kasvaa potilaan mukana. Sydänlihaskudoksen monimuotoisuus ja 
järjestyneisyys luovat haasteita kudoskorvikkeen valmistukseen laboratorio-
olosuhteissa. Tässä opinnäytetyössä hyödynnettiin bottom-up -tekniikkaa, jossa 
kudosimplantti kootaan pienemmistä eri solutyyppien rakenneosista suuremmaksi ko-
konaisuudeksi. Työn tavoitteena oli soveltaa erilaisia mikrovalmistustekniikoita 
fibriinigeelirakenneosien valmistukseen ja myöhemmin koota nämä rakennuspalikat 
yhteen muodostamaan kolmiulotteinen, mikrotasolla hyvin järjestäytynyt ja sähköim-
pulsseja johtava kudosimplantti.  
Fibriinipohjaisten mikrometrikokoluokan 3D kudosrakenteiden valmistamiseen so-
vellettiin kahta eri mikrovalmistustekniikkaa: muovaukseen perustuvaa pehmeän 
litografian MIMIC (micromolding in capillaries) -tekniikkaa sekä fibriinikuitujen 
ekstruusiota. MIMIC:n avulla muovatuissa fibriinigeelirakennelmissa solut 
järjestäytyivät pituussuunnassa muodostaen hyvin tiiviisti organisoitunutta kudosta. 
Ekstruusiolla valmistetuissa fibriinikuiduissa endoteelisolut siirtyivät kuitujen pinnalle 
ja muotoutuivat putkimaisesti fibriinigeelikuidun ytimen ympärille muistuttaen 
tubulogeneesi-ilmiötä. Kokoamalla nämä kudosrakenneosat yhteen voidaan valmistaa 
sydänkudosimplantti, joka koostuu useasta toiminnallisesta yksiköstä (esim. järjestäyty-
neet sydänlihassolut, verisuonitus). Käyttäen hyväksi bottom-up -kudosteknologiaa voi-
daan muodostaa järjestäytynyttä kudosta pienemmistä rakennepalikoista ja täten matkia 
natiivin sydänlihaskudoksen eri solutyyppien monimuotoisuutta ja järjestäytyneisyyttä. 
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1 INTRODUCTION 
The impairment of atrioventricular electrical conduction (AV-block) in the heart due to 
congenital or acquired disorders is a major cause for pacemaker implantation. In AV-
block, the transfer of electrical impulses from the natural pacemaker of the heart 
(sinoatrial node) to the ventricles is partially or completely blocked. This slows down 
the heart rate and decreases the heart's ability to pump blood to the rest of the body. In 
pacing therapy, an electrical pacemaker device is implanted in the chest cavity or 
abdomen. Electrical impulses are delivered to the heart through electrodes that are 
attached in the cardiac muscle to prompt the heart to beat at a normal rate. [1,2] 
Even though pacemaker therapy is the standard treatment today, it has its 
disadvantages. Lead complications can cause severe problems for the patient and 
limited battery life leads to reoperations to replace the power supply. One major 
problem is the implementation of long-term pacing therapy in pediatric patients owing 
to the restrictions imposed by a child’s small size and their inevitable growth. [3,4] Thus 
there is a genuine need for innovative therapies as an alternative to conventional pacing 
therapy especially for children with cardiac rhythm disorders. 
In responding to these challenges, efforts have been made to create a biological 
pacemaker as an alternative to conventional electronic pacemakers. Several research 
groups are focusing on the generation of pacemaker cells by using gene therapy or stem 
cell therapy. [5] Alternatively, developing an autologous biomedical implant using 
tissue engineering strategies could be used to restore conduction between the atria and 
the ventricles.  
The aim of the entire Biopacer project is to develop an autologous conductive tissue 
device that will serve as an electrical conduit between the atria and the ventricles of the 
heart. Pediatric cardiomyocytes are isolated and used together with a fibrin-based 
scaffold to produce a tissue construct that is completely autologous and has the ability to 
grow with the patient. The anticipation is to use this type of engineered tissue to restore 
atrioventricular electrical conduction in children with complete heart block. 
Mimicking the cellular complexity and highly organized structure of native cardiac 
tissue sets significant challenges for the engineering process. To address this challenge, 
bottom-up tissue engineering (TE), in which structural components of different cell 
types with high-degree organization are fabricated separately and later assembled 
together, is applied. This thesis is a part of the Biopacer project and focuses on different 
microfabrication techniques that can be exploited to fabricate fibrin-based structural 
tissue modules that can be used as building blocks to engineer a conductive tissue 
device. The aim is to establish and realize the techniques using fibrin gel, and further 
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exploit them in the fabrication of a conductive tissue device using the bottom-up 
approach. The idea is to utilize techniques of micromolding using soft lithography and 
fibrin fiber extrusion to fabricate cell-laden fibrin tissue modules of different cell types 
with a controllable, spatially organized tissue microarchitecture. Eventually, these 
modules could be assembled together and used as building blocks to create more 
complex 3D tissue constructs using the bottom-up approach.  
The thesis is divided into two parts: a theoretical and an experimental part. The first 
section of the thesis, the theoretical part, provides background information about the 
structure and function of the conduction pathway of the heart and disorders associated 
with it. In addition, biological alternatives to conventional pacing therapy and different 
microfabrication techniques and their use in tissue engineering are described. In the 
experimental part of the thesis, the isolation of autologous pediatric cardiomyocytes is 
presented. Additionally, two microfabrication techniques are established and exploited 
for the fabrication of a conductive tissue device. Each technique is presented and 
discussed in a chapter of its own. Finally, the possibility of combining these techniques 
to produce tissue modules that can be brought together to create more complex tissue 
constructs using bottom-up tissue engineering is explored.  
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2 THEORETICAL BACKGROUND 
2.1 The heart 
The heart is a hollow, muscular organ that contracts continually and pumps blood 
throughout the rest of the body. It is a complex structure consisting mainly of cardiac 
muscle and connective tissue. The heart beats as a result of electrical impulses initiated 
and conducted in the cardiac muscle tissue. [6] In the following chapters, the structure 
and function of the heart specifically the cardiac conduction system is presented in more 
detail. 
2.1.1 Anatomy of the heart 
The heart is comprised of two halves, left and right, which function as separate pumping 
units. Both sides consist of two chambers: an atrium and a ventricle. A muscular 
partition, the septum, separates the two halves from each other. The atria receive blood 
returning to the heart as the ventricles pump it away from the heart. The right atrium 
receives oxygen-poor blood from the body and discharges it via the right ventricle into 
the lungs for oxygenation, whereas the left atrium of the heart receives oxygen-rich 
blood from the lungs and pumps it via the left ventricle to the rest of the body. [6] 
The heart is a part of the complete circulatory system, which also includes the blood 
vessels and of course the blood itself. This system can be divided into two: the 
pulmonary and the systemic circulation. Both begin and end at the heart: the pulmonary 
circulation transfers blood between the heart and the lungs whereas the systemic 
circulation carries blood between the heart and the organ systems. [6] 
2.1.2 Cardiac Tissue 
At cellular level, the heart is composed mainly of cardiac muscle cells 
(cardiomyocytes), fibroblasts, endothelial cells, and smooth muscle cells. All cell types 
have a distinctive role in the structure and function of the cardiac tissue: cardiomyocytes 
play a role in the pumping of the heart, fibroblasts give structural support by 
synthesizing the extracellular matrix (ECM), and vascular cells, endothelial and smooth 
muscle cells, form the vascularization of the tissue. [7] 
In terms of volume, cardiomyocytes make up the majority of the myocardial tissue. 
The rest are non-myocytes, mainly fibroblasts but also endothelial cells. [8] Even 
though in terms of volume endothelial cells and fibroblasts are the minority, they both 
outnumber cardiomyocytes. For example, capillaries formed by endothelial cells are 
found beside every cardiomyocyte to ensure sufficient supply of oxygen and nutrients to 
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the contracting cells. Also, fibroblasts are found surrounding cardiomyocytes providing 
structural support and bridging the spaces between the myocardial tissue layers. [9,10] 
 
 
Figure 1. Cardiac tissue consists mainly of cardiomyocytes, fibroblasts, and endothelial 
cells (not displayed). Picture adapted from [11]. 
 
There are two types of cardiomyocytes: contractile cells and autorhythmic 
pacemaker cells. About 99% of the cells are contractile. These cells consist of 
contractile myofilaments (e.g. actin and myosin) that are organized close together to 
form striated myofibrils. They are responsible for the contraction force of the 
myocardium, but are not capable of generating action potentials. The rest 1% of 
cardiomyocytes are pacemaker cells, which are smaller in size and lack the organized 
myofilament structures. These cells are found along the electrical conduction system of 
the heart and their task is to initiate action potentials and thus set the pace for the 
heartbeat. [2,12] 
A single cardiomyocyte, which contracts approximately 3 billion times in an 
average human lifespan, forms a synchronized beating unit with neighboring myocytes. 
This coordinated contraction activity creates the force for the heart to pump blood 
throughout the body. [12] The cardiomyocytes connect to each other through specified 
junctions at the end of the cells. These cell junctions are called intercalated disks (see 
figure 1) and consist of two components: desmosomes and gap junctions. The 
desmosomes give mechanical support to hold the cells together as the gap junctions 
allow electrical impulses to spread from one cell to another. Upon action potential 
initiation, the signal spreads to all other cells in the surrounding muscle tissue that are 
connected by gap junctions and leads to a coordinated, synchronized contraction of the 
cardiomyocytes. This network of cardiomyocytes connected through gap junction 
connections form a single contraction unit –a functional syncytium. Both the atria and 
the ventricles form their own functional syncytium. This ensures the synchronized 
contraction of alike chambers but separate contraction of the upper and lower part of the 
heart. [6] 
!"#$%&'('#$)*)!+,+**
-.%/.('+#+*&'%)!/01/&1#$+*
234*
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2.1.3 Electrical conduction system of the heart 
The heart pumps as a result of the generation and conduction of electrical impulses. 
Specific cells in the heart, pacemaker cells, initiate spontaneously action potentials 
which spread throughout the heart and causes rhythmical contraction of the heart 
muscle. The pathway of theses impulses is called the conduction system of the heart 
(figure 2). It is made up of several subcomponents, all which have a distinct role in the 
generation and the conduction of electrical signals. [2,6] 
 
 
Figure 2. Electrical conduction system of the heart. Figure from [13]. 
 
The sinoatrial (SA) node is the main pacemaker of the heart and thus sets the 
beating rhythm of the rest of the heart. The SA-node lies in the right atrial wall and is 
composed of cells with the most rapid action potential initiation rate (figure 2a). The 
impulse then propagates to the left atrium via Bachmann’s bundle (figure 2b) and 
through three intermodal tracts (figure 2c) to the atrioventricular (AV) node, which is 
located at the base of the right atrium close to the septum that divides the atria (figure 
2d). It is the electrical connection of the atria and ventricles through a fibrous insulating 
layer of connective tissue. The main function of the AV-node is to delay the impulse to 
ensure enough time for the atria to contract and thus empty of blood before ventricle 
contraction. From the AV-node, the signal passes to the ventricular conduction network, 
which consists of the AV-bundle, bundle branches (figure 2e), and the Purkinje fibers 
(figure 2f). This network rapidly propagates the signal to the ventricles, which then 
contract synchronously. [2,6]  
A. Sinoatrial (SA) Node 
B. Bachmann’s Bundle 
C. Internodal  
Tracts  
E. Left Bundle Branch  
E. Right Bundle Branch  D. Atrioventricular (AV) Node 
F. Purkinje Fibers 
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As mentioned earlier, the pacemaker cells are autorhythmic and non-contractile cells 
– their task is to initiate action potentials and propagate them rapidly along the 
conduction pathway. About 1% of the cardiac muscle cells are like this, the rest are 
contractile cells that take care of the mechanical contraction work. Autorhythmic cells 
are found along the conduction pathway in the SA-node, AV-node, AV-bundle, and 
Purkinje fibers. All these sites can thus act as pacemakers, but the rate at which action 
potentials can be initiated varies. [6] 
The SA-node is the main pacemaker of the heart, consisting of cells with the fastest 
rate of action potential initiation, as the other components in the later stages of the 
conduction pathway are called latent pacemakers. The SA-node generates about 70-80 
impulses per minute and thus drives the heart at this rate. If for some reason the SA-
node fails to generate impulses, the AV-node takes over. It can produce about 40-60 
action potentials a minute. The AV-bundle and the Purkinje fibers can also generate 
impulses (20-40 action potentials per minute) but at much lower rates. Abnormalities in 
the pacemaker action of the heart can lead to severe problems, as the heart is not able to 
pump blood properly to the rest of the body. [2,6] 
2.1.4 Cardiac conduction disorders & conventional therapy 
In cardiac conduction diseases, the pathway of the electrical impulses in the heart is 
damaged or completely blocked which can lead to life-threatening rhythm disorders. 
The damage can occur at any stage of the conduction pathway and can influence the 
impulse generation, conduction, or even both. [14]  
A common conduction disorder, known as heart block, is the impairment or 
blockage of the conduction pathway between the atria and the ventricles. This leads to a 
decrease in heart rate and cardiac output. There are several levels of heart block 
according to the severity of the impairment. In first-degree AV-block, conduction of 
electrical impulses through the AV node occurs but the impulse propagation is 
abnormally prolonged. In second-degree block, conduction occurs only with some 
signals and in third-degree AV-block, the conduction pathway is completely blocked. 
[1]  
In adults, the impairment of AV conduction is most often due to acquired conditions 
such as myocardial ischemia, age-related degeneration, or procedural complications.  
[14] In children, disorders can either be acquired (e.g. surgical complications, infectious 
disease) or congenital (e.g. maternal immune disease, structural abnormalities, long QT 
syndrome). The state-of-art treatment in conduction disorders, to restore heart rate and 
rhythm to normal, is the implantation of a pacemaker device. [4] 
A pacemaker is an electrical medical device, consisting of a computerized generator, 
a battery, and wires with electrodes, that is used to regulate the heartbeat. It is implanted 
in the chest cavity or the abdomen, while the wires are guided to the heart. Electrical 
impulses are delivered to the heart through electrodes that are attached in the cardiac 
muscle to prompt the heart to beat at a normal rate. [15] 
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Even though implantation of an electrical pacemaker device is the standard 
treatment today, it has its disadvantages. Lead complications (e.g. dislocation, fracture, 
improper stimulation) can cause severe problems for the patient and limited battery life 
leads to reoperations to replace the power supply. [16] Especially in pediatric patients, 
the implementation of long-term pacing therapy is a major problem due to the small 
anatomical size of a child and their inevitable growth. Most often pacemaker leads need 
to be positioned epicardially rather than transvenously, which is much more invasive 
and increases the risk for complications. Re-operations are usually inevitable due to 
finite battery life and lead dislocations caused by size mismatch but lead to extensive 
scarring and high risk of infection. [3,4] Thus there is a genuine need for innovative 
therapies especially for children with cardiac rhythm disorders. 
2.1.5 Biological pacemakers 
Due to the drawbacks in conventional pacemaker therapy, alternative biological 
approaches are being explored. A number of research groups are focusing on the 
generation of pacemaker cells by using different cell manipulation techniques and 
various cell sources. The areas of interest can be roughly subdivided into three 
categories: gene therapy, cell therapy, and tissue engineering (figure 3). [3,17] 
 
 
Figure 3. Biological alternatives to conventional pacing therapy. Pictures for schematic 
from [11,17-20]. 
Conventional pacing therapy 
Implantation of a pacemaker 
tage of the positively shifted voltage-dependent activation
kinetics of SkM1, which would permit more channel opening
than with Nav1.5 channels at depolarized membrane poten-
tials.98 Together with gap-junctional modification, these stud-
ies begin to develop a novel toolkit for altering electric
conduction by focal gene transfer.
Future Directions
Efforts to create biological alternatives to present antiarrhyth-
mic therapies, particularly biological pacemakers, have led to
multiple innovations. Figure 6 summarizes the distinct ap-
proaches that have been deployed to initiate automaticity in
usually quiescent working myocardium. The genes-only strat-
egy (top row) either overexpresses an excitatory gene, or
suppresses IK1, to induce automaticity. The hybrid gene–cell
approaches (middle rows) rely on gap-junctional coupling or
cell fusion to relay the excitatory effects of an HCN gene.
Finally, the use of stem cells (bottom row) relies on the
endogenous complement of ion channels in hESC-derived
cardiomyocytes to drive the enhanced automaticity.
In addition to new conceptual insights that merit consider-
ation in the further development of biological pacing, much
more work will be required on focal delivery of constructs/
cells to the myocardium to reduce these concepts to practice.
For example, injection of biological agents into the endocar-
dium via an intracardiac injection catheter represents a
potentially attractive percutaneous delivery route. Likewise,
localized coronary circulation may allow isolated delivery to
small regions of the heart (as was achieved with the AV
node10). Highly localized biological delivery will be particu-
larly effective for arrhythmias in which focal modifications of
electric properties suffice for effective treatment. Because the
amount of exogenous biological material delivered can be
correspondingly reduced, potential problems attributable to
widespread dissemination may be more readily averted. A
singular advantage of focal modification is reversibility: if
needed, implanted biological pacemakers can be destroyed by
conventional electrophysiological ablation, followed by elec-
tronic pacemaker implantation.
Different clinical scenarios may call for different gene deliv-
ery vectors. Adenoviral vectors, for example, achieve the peak
expression earlier than other vectors albeit in a transient manner.
This would be ideal for the temporary pacing needs to treat
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In gene therapy, direct manipulation of so called “pacemaker genes” in contractile 
myocytes has been used to induce pacemaker activity in cells. For example, adenoviral 
vectors have been used to deliver certain ion channel encoding genes, e.g. 
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated (HCN) ion 
channel, into contractile myocytes in an attempt to overexpress distinguished pacemaker 
ion channels. The overexpression of HCN2 channels to elicit pacemaker activity has 
been displayed in a canine model. [21] 
Miake et al. used viral gene transfer to suppress inwardly rectifying potassium 2 
(Kir2) channels in ventricular myocytes to unleash pacemaker activity. Injection of 
these cells into the ventricle of guinea pigs resulted in spontaneous, rhythmic electrical 
activity in vivo. [22] Kashiwakura et al. manipulated a synthetic pacemaker channel 
based on potassium voltage-gated channel subfamily A (Kv1) ion channels by site-
directed mutagenesis. Gene transfer of these synthetic pacemaker channels using a viral 
vector induced pacemaker activity in guinea pig adult ventricular myocardium. [23] 
Although these approaches have showed great potential in animal models, the use of 
viral vectors is not an option in clinical applications. [17] 
A combination of gene and cell therapy has also been proposed. Human 
mesenchymal stem cells (hMSCs) have been used as vehicle for gene delivery to 
provide an alternative for viral vectors. [17, see 24] Human MSCs were manipulated to 
overexpress HCN2 channels through plasmid transfection and injected into the canine 
left ventricular wall. The idea was to impart pacemaker currents (If) to myocardium 
through electronic coupling of myocytes with the transfected hMSCs. This induced 
spontaneous rhythms of left-sided origin on chronic AV-block in the animals. The 
pacemaker activity persisted for approximately six weeks. [17, see 25] The use of 
hMSC compared to viral vectors as delivery vehicles in gene therapy is more attractive 
as they can be acquired in large quantities and are claimed to be immune-privileged. On 
the other hand, in order for this approach to function, high-degree of gap-junction 
coupling between the injected cells and the host myocytes is needed. The stability of 
these junctions is problematic and more research on this part is still needed. [17]   
Plain cell therapy using human embryonic stem cells (hESCs) (as stand-alone with 
no genetic modification) as biological pacemakers has also been explored as an 
alternative. Spontaneously beating human embryoid bodies (EBs) formed by in vitro 
culture of hESCs were injected into the left ventricular wall of guinea pigs. Spontaneous 
action potentials were displayed from the left ventricular epicardium by ex vivo optical 
mapping. Controls (uninjected or saline-injected) showed no signs of action potentials. 
The major obstacle to overcome in using hESCs in clinical applications is host immune 
response and tumorigenesis. [26,27] Over all, even though many advances have been 
taken in the field of gene and cell therapy, there are many hurdles to overcome in both 
the use of hESCs and vector-mediated manipulation of human cells in pacing therapy 
before it can be considered clinically relevant. [17] 
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The use of tissue engineering (TE) as an alternative biological approach to 
conventional pacemaker therapy has also been explored [3]. Tissue engineering is “… 
an interdisciplinary field that applies the principles of engineering and the life sciences 
toward the development of biological substitutes that restore, maintain, or improve 
tissue function”, as described by Langer and Vacanti in 1993 [28].  
Steps have been taken into the direction to create a 3D conductive tissue implant 
using cells and different scaffold materials to restore AV conduction in the heart. An 
engineered 3D tissue implant would offer more precisely targeted delivery of the cells 
to the heart compared to cell injection-based methods described earlier. [3] Also by 
using autologous materials, immune host response could be prevented.  
The idea of fabricating a conductive tissue construct using tissue engineering has 
been approached by Choi et al. They fabricated collagen-based semi-cylindrical 3D 
constructs containing fetal rat myoblasts from skeletal muscle. These constructs were 
implanted in the AV-groove of rat hearts to propose an alternative conduction pathway 
between the atria and the ventricles. Electrical coupling of the cells within the construct 
was demonstrated through expression and function of gap junction proteins. Also, the 
cells were shown to survive at the implantation site for the entire duration of the 
animal’s natural life. However, their design resulted in nearly instantaneous atrial to 
ventricular depolarization, which is not consistent with the function of the delaying 
property of the AV-node. This could lead to undesired arrhythmias in the heart. Choi et 
al. proposed alternative cell sources with more desirable conduction properties should 
be explored. Nevertheless, this showed that it is possible to electrically connect the atria 
and the ventricles through engineered tissue constructs and thus steps are taken into the 
right direction in the developing of a tissue engineered biological alternative to 
conventional pacemaker devices. [3] 
2.2 Engineering conductive tissue 
In this chapter, the principle of tissue engineering (TE) is presented. The benefits of 
using hydrogels, especially fibrin gel, in TE are highlighted and the criteria for 
engineering conductive tissue for the heart presented.  
2.2.1 Principle of tissue engineering 
The principle of TE is presented in figure 4. The idea is use cells from a patient, 
combine them with a scaffold to create a 3D tissue construct, and implant it at the site 
where it is needed to replace or restore defective tissue. Autologous cells can be isolated 
from a tissue biopsy taken from the patient. The cells are amplified in vitro to achieve 
sufficient quantity and are combined with a scaffold. The construct is cultivated e.g. in a 
bioreactor for further tissue development. After this, the viable tissue construct is 
implanted in the patient as an autologous replacement. [28] 
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Figure 4. Principle of tissue engineering. Pictures for schematic from [11,29,30].   
2.2.2 Fibrin-based tissue engineering 
The scaffold is used in TE as a platform for the cells to organize themselves into a 3D 
architecture – in other words it serves as a synthetic ECM to the cells. A suitable 
scaffold for use in TE needs to meet some specific requirements. First of all, the 
scaffold needs to be completely autologous and neither the scaffold material nor its 
degradation products should cause any toxicity or inflammation in the body. Also, it 
should promote cell adhesion and proliferation, degrade controllably to adapt to the 
developing tissue, and allow homogenous cell distribution to facilitate uniform tissue 
formation. Easy fabrication of the material into 3D structures and high mechanical 
strength are also desirable characteristics. [29,31] 
Hydrogels have received much attention in the field of TE for their structural 
similarities to the natural ECM. Hydrogels are 3D networks of cross-linked hydrophilic 
polymers and are thus highly hydrated materials. Several hydrogel materials, both 
synthetic and natural, have been used in TE applications. [32] 
Fibrin gel is an attractive material for TE applications as it fulfills many of the 
criteria set for the scaffold. Fibrin is the major protein component involved in wound 
healing. It is converted from fibrinogen, a plasma protein, by the action of thrombin and 
calcium. The main components for the scaffold, fibrinogen and thrombin, can be 
autologously derived directly from the patient’s blood, which prevents problems of 
immunogenicity. As the starting components of blood are in solution form, gels can be 
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easily molded into the desired construct e.g. through injection molding. Also, fibrin gel 
provides high cell seeding efficiency and homogenous cell distribution by gelation 
entrapment. [29] The degradation of the fibrin gel can be controlled by the use of a 
fibrinolysis inhibitor tranexamic acid [33]. 
2.2.3 Principle of the Biopacer 
The idea of the Biopacer project is to develop an autologous conductive tissue device 
(CTD) that will serve as an electrical conduit between the atria and the ventricles of the 
heart. Pediatric cardiomyocytes are isolated and used together with a fibrin-based 
scaffold to produce a tissue construct that is completely autologous and has the ability to 
grow with the patient. The anticipation is to use this type of engineered tissue to restore 
atrioventricular electrical conduction in children with complete heart block. 
 
 
Figure 5. Principle of engineering a conductive tissue device (Biopacer). 
2.2.4 Requirements for engineering a conductive tissue device  
There are specific aspects, structural and functional, of the native AV node that need to 
be taken into account when engineering a CTD. First of all, the engineered tissue should 
consist of several cell populations (cardiomyocytes, fibroblasts, endothelial cells). [7] 
These cells should either rearrange themselves within the scaffold or be arranged by 
assembling functional tissue units separately to achieve the complex, highly organized 
native tissue-like architecture. [34] All these cell types have a specific role in the 
structure and function of the tissue. Cardiomyocytes make gap junctions with each other 
to form a functional syncytium to allow propagation of electrical impulses. Fibroblasts 
play a significant role in providing mechanical stability to the structure by synthesizing 
ECM. Endothelial cells, on the other hand, provide the vascularization to ensure 
sufficient oxygen and nutrition supply. [7] All these cell types need to be accounted for 
in order to fabricate a functional conductive tissue device. It is noteworthy to take into 
account that cardiomyocytes have a very limited or even nonexistent potential to 
proliferate. [7] This means, that the availability of the cell source plays a significant, 
usually limiting, role in engineering conductive tissue for the heart.   
The engineered CTD should integrate into the implantation site in a way that the 
cells from the engineered tissue would electromechanically couple with the existing 
cells in the conduction pathway to allow the propagation of impulses from the atria to 
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the ventricles [7]. Also, the electrical impulses should propagate one-way at normal 
atrial activation thresholds and not give rise to the potential of arrhythmogenesis. 
Ideally, the engineered tissue device would also delay conduction as occurs in the native 
AV-node. To be applicable for clinical applications, the engineered tissue device should 
be autologously derived, easy to fabricate and implant, and it should have the potential 
to grow with the patient while maintaining conduction capability. [3] The use of 
autologous cells maximizes patient safety as it decreases the risk of immunogenic 
response. To be considered as long-term pacing therapy, it should function for the 
lifespan of the patient minimizing the need for reoperations. 
2.2.5 Bottom-up tissue engineering 
Traditionally, tissue constructs are fabricated using a top-down (figure 6b) approach: 
cells and a scaffold material are combined and cultured with the aid of e.g. perfusion or 
mechanical stimulus until the cells remodel the support structure by producing the 
ECM. However, this requires the cells to rearrange themselves in complex tissue-like 
microarchitecture. For most tissues, having the right microarchitecture and well-defined 
cellular organization is crucial. For example cardiac tissue is highly organized and 
cardiomyocyte cell-cell interactions are extremely important to the functionality of the 
tissue. Thus trying to mimic the alignment and high-degree organization of native 
cardiac tissue is advantageous to engineering functional tissue constructs. [35] 
 
 
Figure 6. Bottom-up (A) and top-down (B) approaches in tissue engineering. Picture 
from [36].  
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This is the aim in bottom-up (figure 6a) tissue engineering, in which microscale 
structural features of tissues are fabricated as modules and combined together to create 
larger tissue constructs. In other words, tissue modules can be used as building blocks to 
create biomimetic hierarchical structures. Several microfabrication techniques have 
been used to create spatially organized tissue modules. [34,36] By fabricating structures 
in microscale, the cell-cell interactions can be evaluated better and the quantity of cells 
needed for fabrication can be minimized.  
The group where this thesis was carried out has extensive experience and knowledge 
in cardiovascular tissue engineering. However, the techniques applied and established 
by the group have always been done using the top-down approach. In this thesis, 
microfabrication techniques that can be used to fabricate constructs using the bottom-up 
approach are established for the group. Two methods are presented and exploited to 
create cell-laden hydrogel modules that can be applied in the fabrication of a conductive 
tissue device.  
Because of the complexity of the cardiac tissue with all the different cell types and 
the high-degree of organization, the application of microfabrication techniques is 
attractive in creating a CTD. Tissue modules of different cell types (e.g. 
cardiomyocytes, fibroblasts, and endothelial cells) can be microfabricated separately 
and later assembled together. This way, the organization and tissue formation of the 
separate components (e.g. vascularization, ECM) can be preformed and then combined 
to create a more complex but highly structured construct.  
This thesis focuses on two fabrication techniques that can be used to create cell-
laden hydrogel tissue modules and on how these components could be used as building 
blocks to further assemble larger scale CTD that would incorporate all the structural 
components (aligned cardiomyocytes, vasculature, ECM) present in native tissue. 
However, the microfabrication techniques established here can be transferred to various 
other TE applications and thus go far beyond the mere fabrication of a conductive tissue 
device. These methods could be used to tackle microvasculature insufficiency of 
engineered tissue, which is a major problem in TE. By preforming the structural outline 
for capillary formation using cell-laden hydrogel microstructures, vascular development 
could be induced and thus the problem of insufficient vascularization of engineered 
tissue constructs that exceed the diffusion limits of oxygen and nutrients could be 
confronted. Alternatively, the techniques could be used to fabricate multiple small-scale 
functional units, which could be stacked or assembled together to form tissue constructs 
consisting of repeating functional units. This could be advantageous for engineering 
tissue for example for the liver, which consists of repeating functional units (lobules). 
2.3 Microfabrication techniques 
Microfabrication technology is a generic term for techniques that allow the fabrication 
of miniature components and devices with micrometer resolution [37]. In tissue 
engineering, a number of techniques, e.g. emulsification, photolithography, 
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microfluidics, and micromolding, have been established to allow fabrication of 
microscale hydrogel tissue structures. These techniques can be used to engineering 
small, biologically relevant size structures with a controllable shape (spheres, 
rectangular blocks, fibers etc.). Fabrication of hydrogels in microscale with controlled 
3D arrangement of cells can provide a way to mimic complex structures and 
architectures of biological tissues. [34,38]  
In this thesis, two microfabrication techniques are used to fabricate fibrin hydrogel-
based scaffolds for TE purposes: micromolding in capillaries (MIMIC) using soft 
lithography and fabrication of microfibers by extrusion. 
2.3.1 Soft Lithography 
Soft lithography is a group of techniques designed to fabricate microscale or nanoscale 
structures of soft materials (e.g. polymers, gels, and organic monolayers) based on 
printing, molding, and embossing. The methods are all based on using a patterned 
elastomeric polymer as a mask, stamp, or mold. These techniques came to life to 
provide a low-cost, simple, and cell compatible alternative to photolithography and 
electron-beam lithography. [35,39] 
The main tool in soft lithography is the use of a polydimethylsiloxane (PDMS) layer 
with embossed structures on the surface. The PDMS is fabricated by replicating a 
master as shown in figure 7. PDMS pre-polymer is prepared by mixing two 
components, a base and a curing agent, together. It is then poured over the master and 
cured. Silicone hydride groups in the curing agent react with vinyl groups in the base 
resulting in a cross-linked elastomer. The PDMS can then be peeled off from the master 
completely intact due to low surface free energy and elasticity of the material. [40] 
 
 
Figure 7. Replication of PDMS from a master.  
3. Peel off PDMS 
2. Let PDMS cure 
1. Pour prepolymer on master master 
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2.3.2 Techniques in soft lithography 
The patterned PDMS can be used in a number of different ways –as a mask, stamp or 
mold. The most common applications are presented figure 8 and shortly explained 
below. 
 
!
Figure 8. Techniques used in soft lithography: (A) replica molding, (B) microcontact 
printing (µCP), (C) micromolding in capillaries (MIMIC), (D) microtransfer molding 
(µTM), and (E) microfluidics. Picture from [35]. 
 
Replica molding (figure 8a) is a single step technique used to duplicate the 
topographical patterned surface structures of the PDMS master. It is the same concept 
used to fabricate the PDMS layer –a mold is covered with a liquid polymer, cured, and 
peeled off to form exact structures from the master. The exact dimensions of the 
patterns can be transferred to another polymer.  
In microcontact printing (µCP) (figure 8b), the PDMS is used as a stamp to create 
patterns on surfaces. The stamp surface is submerged into a solution, and then pressed 
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Figure 2 | The core techniques of soft lithography. The key stages of each of the following techniques are shown: 
a | replica moulding; b | microcontact printing; c | micromoulding in capillaries; d | microtransfer moulding; and 
e | microfluidics. f | A PDMS membrane with microfabricated holes created by replica moulding from a master with 
circular posts. g | A curved layer of micropatterned polyurethane created by bending a micropatterned layer of PDMS 
and then replica moulding against it. h | A microfluidic chemostat for the growth and culture of microbial cultures. The 
device incorporates six reactors with an intricate network of plumbing, in a footprint that is approximatley 5 cm2. PDMS, 
poly(dimethylsiloxane). Part (f) reproduced with permission from REF. 74  (2000)  American Chemical Society. Part (g) 
reproduced with permission from REF. 1  (1998) Geselleschaft Deutscher Chmiker. Part (h) reproduced with permission 
from REF. 59  (2005) American Association for the Advancement of Science.
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Figure 2 | The core techniques of soft lithography. The key stages of each of the following techniques are shown: 
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from REF. 59  (2005) American Association for the Advancement of Science.
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onto the surface to transfer the pattern of the stamp to the substrate surface. This method 
has been used to create patterned layers of e.g. proteins and other small biomolecules.  
PDMS can be patterned in a way that when brought together with a surface it forms 
microchannels. The PDMS is sealed to the surface of a solid substrate (e.g. glass slide) 
through van der Waals interactions, forming channels that can then be filled with pre-
polymer. The filling can occur either by capillary action or by suction and after 
polymerization, the PDMS is carefully peeled off to reveal micropatterned lines left on 
the surface of the substrate. This technique is called micromolding in capillaries 
(MIMIC) (figure 8c).  
In microtransfer molding (µTM) (figure 8d), the patterned PDMS layer is covered 
with a pre-polymer and the excess is scraped off. The pre-polymer-PDMS combination 
is then brought into contact with a surface. After polymerization, the PDMS is carefully 
peeled off revealing the patterned polymer structures on the surface of the substrate. 
As previously mentioned, microfluidic channels can be formed by sealing a 
structured PDMS piece with a glass slide. The bond between these two substrates is 
tight enough to allow micromolding of e.g. hydrogels, but channels can leak if the fluid 
is put under pressure. A tighter bond between the two substrates can be made by 
exposing the two surfaces to oxygen plasma, which activates the surface and allows the 
covalent bonding of the PDMS to the glass. This way the microchannels can withhold 
pressures as high as 50 psi exerted from e.g. pumping fluid through the channels. With 
this technique, called microfluidics (figure 8e), a sealed microfluidic device is formed. 
[35,39] 
2.3.3 PDMS properties 
PDMS is a transparent, elastomeric silicon-based organic polymer. Liquid PDMS 
conforms to the shape of a mold and, due to low surface free energy and elastomeric 
behavior, it also releases easily from them. This makes it a very attractive material for 
use in soft lithography applications. The transparency of the material is good for 
visualization purposes. It is also impermeable to liquid but allows gases to pass through 
the bulk material. Most important, PDMS is non-toxic and inert which makes it 
compatible for use in TE approaches. [40] 
PDMS contains repeating –OSi(CH3)2 units which makes it hydrophobic [41]. In 
micromolding and microfluidic applications, a hydrophilic surface is required to 
promote the filling of the channels and also to ease the sealing of the PDMS to the 
wanted surface. This can be achieved by treating the PDMS with oxygen plasma. [42]  
PDMS seals easily to itself or other surfaces and it can be done reversibly or 
irreversibly depending on the wanted outcome. Reversible sealing enables the use of 
PDMS to pattern for example biomolecules by stamping or microfluidic molding. The 
PDMS can be easily peeled off the surface and even re-used if wanted. This reversible 
contact, induced by van der Waals contacts, can be made to clean, smooth surfaces 
without even plasma treating the PDMS. If the PDMS surface is first treated with 
oxygen plasma and immediately (<1 min) placed on a clean surface (e.g. PDMS or 
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glass), it will make a permanent bond. An even stronger bond can be made if both 
surfaces are oxidized and then immediately sealed together. [40] This is valuable when 
a microfluidic device is designed to be used under increased pressure e.g. as a flow 
chamber.  
A noteworthy characteristic of microfluidic channels is the laminar flow of fluids; 
the velocity at a given spot in the channel is constant in time. The Reynolds number 
(Re) is a dimensionless value that describes the behavior of fluids. It is described by !" ! !"!!!!, in which ! is the density of fluid (g per cm3), ! is the velocity of the 
fluid (cm s-1), !!is the hydraulic diameter (cm) of the channel, and ! is the viscosity of 
the fluid (g per cm per s). When the Re is less than ~2000, fluid is laminar. A Re over 
~2000 correlates to a turbulent flow. The flow in microchannels, mainly due to the 
small dimensions, is typically laminar, as the Re does not exceed the cut-off value of 
2000. This means that the flow rate at a given region of the channel is constant in time. 
[35] 
In microscopic systems, the surface properties play an increasingly important role in 
the performance of the devices due to increased surface-to-volume ratios. [42] In soft 
lithography applications, special attention needs to be given to the surface properties of 
PDMS, especially to its hydrophobic nature, and how it interacts with different 
biological materials. 
There are two major issues to overcome in using PDMS in micromolding 
applications with hydrogels. First, the hydrophobic nature of PDMS is a major obstacle 
as the filling of the small, microscale channels with aqueous solutions is almost 
impossible unless assisted with suction (e.g. using a Pasteur pipette). A hydrophilic 
surface is compulsory so that the channels can be filled with capillary forces with no 
external assistance needed. Also, a hydrophilic surface allows the PDMS to seal better 
to the wanted surface, in this case a glass slide.  [42] During oxygen plasma treatment of 
PDMS, the methyl groups (Si-CH3) are replaced with polar silanol (Si-OH) groups [41]. 
 
      (1) 
 
The PDMS surface retains its hydrophilic surface for some hours in air but due to 
mobile, low molecular weight monomers migrating from the bulk to the surface it will 
eventually turn hydrophobic again. It has been shown that the time of hydrophilicity is 
highly dependent on the storage conditions rather than the plasma parameters used. Kim 
et al. compared different solutions (e.g. PBS, air, and water) for storage after plasma 
treatment and discovered that water retained the surface hydrophilicity of the PDMS the 
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The second obstacle to overcome is the adhesion of hydrogels to the PDMS. The 
PDMS is used as a temporary mold to fabricate hydrogel lines using micromolding and 
is peeled off the glass substrate after polymerization. The intact demolding of the 
hydrogel lines is possible if the PDMS surface is modified to resist the nonspecific 
adsorption of proteins. [44] Hydrogels, e.g. fibrin gel that is a protein network formed 
by the crosslinking of fibrinogen and thrombin, adsorbs to the PDMS due to the 
hydrophobic interactions. To overcome this problem, the surface of the PDMS is to be 
made hydrophilic to prevent protein adsorption. Treating the surface with only oxygen 
plasma, as already mentioned before, makes the surface hydrophilic but it is not 
sufficient enough to prevent nonspecific protein adsorption. An additional protein-
preventing polymer layer, e.g. PEG or PEO –based, is needed. [45] 
Several groups have used Pluronic® as a surfactant to prevent the adhesion of fibrin 
to PDMS. [46,47] Pluronic® is a non-ionic surfactant used in many biotechnological 
applications to prepare protein-resistant biomaterial surfaces [48]. It is an amphipathic, 
triblock copolymer with a general structure of . Pluronic® has 
low toxicity and immunogenic response making it suitable for use in medical 
applications. [49] In this thesis, Pluronic® F-127 ( ) was used as a 
surfactant.  
Pluronic® binds to the hydrophobic PDMS surface by the PPO segment as the PEO 
tails extend towards the aqueous solution. This conformation makes the surface of the 
PDMS hydrophilic and nonionic, which prevents the adhesion of the proteins to the 
surface. [48] If the PDMS is pre-treated with oxygen plasma, creating a hydrophilic 
surface, and then coated with Pluronic® the conformation of the adsorbed polymer is 
different. The Pluronic® adsorbs in a more flat conformation through hydrogen bonding 
of POE segments to the surface (see figure 9). [49] The PEO can then effectively 
prevent the adsorption of proteins by steric repulsion, as is shown by Amiji et al. with 
fibrinogen. [48] 
 
 
Figure 9. Adsorption of Pluronic F-108 onto non-treated (hydrophobic) PDMS (left) 
and oxygen plasma treated (hydrophilic) PDMS (right). Picture adapted from [49]. 
 
 
 
(PEO)m (PPO)n (PEO)m
m =100, n = 65
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2.3.4 Micromolding of 3D hydrogels using soft lithography 
Microfabrication techniques using soft lithography have been widely used in tissue 
engineering. In this chapter, an overview is presented on how these techniques have 
been utilized to micromold 3D hydrogel constructs for TE applications. 
Bian et al. fabricated muscle tissue constructs using PDMS tissue molds with 
mesoscopic-sized posts in order to form a muscle sheet with elliptical pores formed 
around the posts. A mixture of skeletal muscle cells and fibrin gel were cultured in the 
PDMS molds for two weeks. Due to gel anchorage at the end of the posts and tissue 
contraction, a strain field formed within the gel, which guided the cells to align along 
the pore boundaries. Evaluation of the tissue showed that the technique induced cell 
alignment in the 3D constructs. [46] 
Trkov et al. studied vasculogenesis under spatially controlled conditions by using 
MIMIC. A mixture of endothelial cells and fibrin gel was molded in parallel 
microchannels to evaluate the interactions of the cells (e.g. sprouting) with each other as 
a function of distance over time. Endothelial cells of several different origins were used 
in the experiments. [50] 
Raghavan et al. also spatially patterned endothelial cells within micromolded 
hydrogels in the attempt to evaluate the possibility to control endothelial tubulogenesis. 
They used microstructured PDMS with parallel grooves to form collagen gel tubes with 
cells embedded inside. The PDMS mold was faced grooves upwards, and the collagen-
cell mixture was added on top. The excess was scraped so that only the grooves were 
filled. The tubes were then cultured and later the tubes were embedded with more 
collagen and removed from the PDMS mold. This method of organizing cells within 
channels filled with collagen created a novel platform to promote endothelial 
tubulogenesis. [51] 
McGuigan et al. described a soft lithography technique to encapsulate cells in 3D 
gel modules of different shapes (e.g. pillars). A master that consisted of pillars with 
diameters ranging from 40 to 1000 µm was cast with PDMS to replicate a PDMS 
membrane with holes of the same dimensions. These holes were used as molds to 
fabricate round pillar-shaped 3D hydrogels (e.g. collagen, Matrigel™, and agarose) 
encapsulated with cells. The membrane was submerged into the gel-cell suspension. 
After incubation, the faces of the membrane were removed of excess gel and the 
modules embedded in the holes were gently shaken out into further cultured in 
suspension. This technique allowed the fabrication of 3D hydrogel modules of various 
different shapes. [52] 
Yeh et al. micromolded cells encapsulated into methacrylated hyaluronic acid 
(MeHA) or poly(ethylene glycol) diacrylate (PEGDA) hydrogels using a PDMS stamp. 
Cells were suspended in pre-polymer solutions along with a photoinitiator and deposited 
onto a PDMS mold. A PDMS coverslide was placed on top and the polymer liquid was 
photopolymerized using ultraviolet (UV) light. After polymerization, the coverslide was 
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removed revealing the cell-encapsulated microgels which could be further cultivated. 
[53] 
2.4 Fabrication of microfibers for tissue engineering 
applications 
Microscale tubular tissue constructs, microfibers, have been fabricated mainly by 
utilizing microfluidics. The unique laminar-flow properties within microfluidic channels 
present an advantages approach to generating hydrogels with controlled features. 
Several materials, both synthetic and natural, have been explored as options in creating 
hydrogel-based microfibers for TE. [54] 
Previously, hydrogel-based microfibers have been generated for TE purposes by 
using conventional spinning methods. Hu et al. used a triple-orifice spinneret to 
fabricate hollow and solid fibers of gelatin-hydroxyphenylpropionic acid (Gtn-HPA) 
[55]. A similar spinning method was used by Takei et al. to generate hollow alginate 
microfibers [56].  
More recently, the fabrication of hydrogel microfibers has moved into the direction 
of utilizing microfluidic devices. Co-axial flow-based microfluidic devices embedded 
with a glass capillary tube have been used to fabricate microfibers of different shapes 
and sizes. [54] Shin et al. used this technique to form calcium alginate microfibers. By 
controlling the flow rate, the diameter of the fibers could be modulated. Cells were 
encapsulated into fibers successfully to demonstrate the possibility of the technique for 
tissue engineering purposes. [57] Other materials, such as poly(lactic-co-glycolic acid) 
(PLGA) and chitosan, have also been used to fabricate microfibers [54,58,59]. Hwang et 
al. fabricated PLGA microfibers of different diameters using a co-axial flow-based 
microfluidic device by altering the flow rate. They investigated the effects of the 
diameter of microfibers on cellular orientation by culturing fibroblasts on the surface of 
the PLGA fibers. They demonstrated that the orientation of the cells increased with 
decreased diameters. This provides a technique that can be applied to form aligned 
tissue. [59]. Chitosan microfibers have been fabricated using a cylindrical 
microchannel-based approach, without the use of glass capillary tubes. Kang et al. 
fabricated chitosan fibers of different compositions in multiple channels at a time 
scaling up the production process.  [54,58] The flow-based microfluidic device has also 
been used to fabricate photocrosslinkable hydrogels, e.g. 4-hydroxy butyl acrylate (4-
HBA) and polyvinyl alcohol (PVA), into fibers [59]. 
Shimoyama et al. used a plain capillary glass tube as a microfluidic channel to 
fabricate highly aligned fibrin microfibers. They seeded skeletal muscle cells on the 
surface of the fibers, which migrated into the bulk, aligned in the longitudinal direction, 
and formed multinucleus myotubes. This demonstrated a novel approach to fabricate 
highly aligned skeletal muscle fibers for TE. [60]  
Cornwell et al. also used fibrin as a material to fabricate microfibers. Fibers were 
fabricated by coextruding fibrinogen and thrombin through polyethylene tubing. By 
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assembling microfibers together, larger scale scaffolds were formed either by bundling 
the fibers together without crosslinking or using UV light as a crosslinking agent. The 
uncrosslinked constructs were shown to support fibroblast proliferation and cellular 
alignment as the UV crosslinked constructs exhibited high mechanical properties but 
failed to support cell proliferation. The anticipation was to take advantage of the wound 
healing properties of fibrin by using the fibrin microfibers to help guide wound healing 
by directing cellular responses in the aligned system to the injury site to induce the 
regeneration. [61] 
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3 CARDIAC AURICLE AS A SOURCE FOR 
AUTOLOGOUS CARDIOMYOCYTES 
A mixed population of cells for primary culture is obtained from the right auricle of 
pediatric patients two months to eleven years of age undergoing open-heart surgery. 
Consent is required from the parents for the use of the tissue for research purposes. The 
surgical procedures were carried out at the Department of Heart Surgery for Children 
and Adults with Congenital Heart Defects at the University Hospital Aachen (UKA).  
The cardiac auricle is an ear-shaped appendage found on both atriums of the heart. 
The tissue contains a mixed population of cells, e.g. cardiomyocytes and fibroblasts. 
During open-heart surgery, a heart-lung machine is used to replace the function of the 
heart and lungs. When connecting the patient to the heart-lung machine, a cannula is 
inserted into the right atrium to draw blood from the body, which is then oxygenated, 
and brought back to the body. During the insertion of the cannula into the atrium, a 
small piece of tissue is obtained from the atrial appendage as “waste material”.  
3.1 Materials and methods 
3.1.1 Cell isolation  
After surgery, the sample is transported in sterile conditions to the Helmholtz Institute 
Laboratory in a transport buffer, which is composed of calcium-free Krebs buffer 
solution (KRP) and 2,3-Butanedione monoxime (BDM) (appendix 1). The tissue sample 
is stored in the buffer at 4°C until the start of the isolation procedure.  
Cells are isolated according to an enzymatic isolation protocol that has been 
previously used in the group. The complete isolation procedure is done sterile in a class 
II laminar flow bench (Heraeus HeraSafe HS 12). First, the connective tissue is 
removed and the sample is cut into small pieces using a scalpel (Feather Disposable 
Scalpel No. 23). The pieces are collected with tweezers and placed into a 50 ml falcon 
tube (BD Biosciences) with 45 ml of sterile KRP+BDM buffer. The falcon with the 
tissue pieces is gently mixed for five minutes and the pieces are left to settle at the 
bottom of the falcon. The supernatant is discarded through a cell sieve (BD Falcon Cell 
Strainer 100 !m Nylon, REF. 352360). This washing step is repeated twice.  
The dissociation of the tissue is done using a two-step enzymatic digestion process. 
First, the tissue pieces are incubated with 5 ml of washing buffer (KRP with 6 U/ml 
proteinase 24, Sigma P-8038; 200 U/ml collagenase, Sigma C-9263) for 30 minutes at 
37°C with constant mixing. The supernatant is discarded through a cell sieve, replaced 
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with a lysis buffer (KRP with 400 U/ml collagenase), and incubated as done previously. 
The solution is put through a sieve to remove any left over solid pieces. The final 
supernatant holds the released cells collected from the isolation. 
The supernatant with the cells is centrifuged for 12 minutes at 200 G and re-
suspended into 4 ml of medium (Gibco Dulbecco`s Modified Eagle Medium (DMEM); 
10% Fetal Bovine Serum, PAA). The cell suspension is seeded out into a 75 cm2 cell 
culture flask (Greiner Bio-One Tissue Culture Flask 250ml 75cm2 with filter) and 
placed into an incubator (Binder CB 210) at 37 °C and 5 % CO2 for four hours. This 
pre-plating procedure is carried out as a purification step to achieve a higher percentage 
of cardiomyocytes in the co-culture, as fibroblasts and endothelial cells adhere faster 
than the cardiomyocytes [62].  
After four hours, the medium along with the non-adhered cells is carefully removed 
with a pipette. This contains the majority of cardiomyocytes that are obtained from the 
isolation, which should be immediately used for experiments as the cardiomyocytes 
have a limited proliferation capacity and do not benefit from being cultured in a flask.  
If further cultured, the fibroblasts that are not eliminated by the pre-plating step 
would eventually take over the entire flask and the cardiomyocytes would be lost. Fresh 
medium is added to the pre-plating flask and the adhered cells, which are mainly 
fibroblasts, are placed in an incubator for further proliferation.  
3.1.2 Immunocytochemistry 
Cells are seeded into 96-well plates (Greiner Bio-One) straight from isolation for 
immunocytochemical staining. The cell culture medium is aspirated and -20°C 
methanol is added for 30 minutes for fixation. The cells are washed using PBS (Gibco 
Dulbecco`s Phosphate Buffered Saline) for 10 minutes and then incubated with 3% 
Bovine serum albumin (BSA, Sigma A-9647) in PBS for 30 minutes to block unspecific 
binding sites. The primary antibody diluted in 3% BSA is added and incubated at 37°C 
for 60 minutes. After washing with 3% BSA twice, samples are incubated with the 
second, fluorescent antibody, diluted in 3% BSA for 60 minutes at 37°C. Samples are 
washed again, now with PBS, and the cell nuclei are counterstained with DAPI 
(Molecular Probes) for five minutes at room temperature. Finally, the cells are washed 
three times with PBS and visualized using a microscope. Negative controls are treated 
as stated above except leaving out the primary antibody during the first incubation. 
Images were taken using an AxioImager microscope (Carl Zeiss) in combination with a 
mounted digital camera (Zeiss, AxioCam MRm).  
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Primary Antibody Company Dilution Secondary 
Antibody 
Anti-Sarcomeric alpha 
Actin 
Thermo Scientific 
(MA1-21597) 
Undiluted Anti-mouse 
 
Secondary Antibody Company Dilution 
Alexa Fluor® 488 
Goat Anti-Mouse IgG 
(H+L) 
Molecular Probes® 
(A11059) 
1:400 
Table 1. Primary and secondary antibodies used for immunocytochemical staining of 
cardiomyocytes.  
3.2 Results and discussion 
Cardiac auricle tissue consists of several cell types (cardiomyocytes, fibroblasts, and 
endothelial cells) and thus a co-culture is obtained from the isolation. In theory, all these 
cell types could be isolated from the cardiac auricle tissue biopsy, but in reality the 
implementation is much more difficult. 
First, the availability of the cell source is very limited due to the fact that biopsies 
are obtained from pediatric patients undergoing open-heart surgery. It is not an 
everyday operation and also consent from the parents is needed. The tissue biopsies 
received are very small in size, which already indicates that large numbers of cells 
cannot be obtained. 
Secondly, a majority of the cells are lost during the isolation procedure. This was 
observed by calculating the cells using a hemacytometer with trypan blue. Trypan blue 
is a dye that selectively colors dead cells blue making it easier to evaluate the relation 
between live and dead cells. After pre-plating, approximately 150 000-400 000 cells, are 
obtained from each isolation. This is a very small cell number to use in preliminary 
experimental studies.  
Generally a very high density of cardiomyocytes is needed for engineering cardiac 
tissue due to the limited proliferation capacity of the cells. For example, Radisic et al. 
used a density of 50-100 million cells/cm3 when engineering collagen-based constructs 
for cardiac TE[63]. This number corresponds to the cardiomyocyte density present in 
the native adult rat heart. Also, lower concentrations have also been used. Ye et al. 
encapsulated rat cardiomyocytes in fibrin gel constructs at a density of 5 million 
cells/ml of gel [47]. Thus the cell number obtained from the isolation is very low to be 
applied in TE approaches.  
If the cells are seeded into flasks for further cultivation, keeping several cell types 
happy at once in a co-culture is very difficult. For example, endothelial cells are quickly 
lost, as the medium used for culture does not support growth and proliferation of these 
cells. Also, cardiomyocytes have a very limited or even nonexistent proliferation 
capacity thus the cell number cannot be amplified by further cultivation. As a result, if 
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the cells are seeded into culture flasks for further cultivation, cells that proliferate the 
fastest and receive a sufficient amount of nutrients, take over. This means that 
eventually the co-culture has turned into a culture of cardiac fibroblasts.  
Even if the cells are used immediately for experiments, the percentage of 
cardiomyocytes obtained from the isolation is very low. Using the pre-plating step in the 
isolation procedure, some of the fast-adhering fibroblasts and endothelial cells can be 
eliminated which somewhat increases the cardiomyocyte purity. In figure 10, the 
immunocytochemical staining of the cells isolated from the cardiac auricle is displayed 
and shows that a co-culture of cells is obtained. Cardiomyocytes stain positive for alpha 
sarcomeric actin (green), a marker for alpha skeletal and alpha cardiac muscle actins. As 
the culture medium used does not support the growth and proliferation of endothelial 
cells, the cells negative for alpha sarcomeric actin can be concluded as cardiac 
fibroblasts. 
 
 
Figure 10. Immunocytochemical staining of cells isolated from a pediatric cardiac 
auricle tissue biopsy (day 42 of culture). Cardiomyocytes stain positive against alpha 
sarcomeric actin (green). Cell nuclei are stained using Dapi (blue).   
 
As a result of the difficulty to obtain sufficient numbers of cardiomyocytes from the 
human cardiac auricle biopsy, the use of microfabrication techniques is explored to 
overcome the limitation of low cell numbers. By creating already aligned or at least 
high-density cardiomyocyte fibrin gel constructs in microscale, the cells can be 
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organized more efficiently compared to homogenously distributing the cells with a 
macro-scale construct using the top-down TE approach. 
For microfabrication applications, smaller volumes of fibrin gel are needed, which 
means that it is easier to fabricate constructs with high cell densities. The volumes used 
in microstructuring can be expressed in microliters as opposed to most top-down TE 
fabricated constructs that require volumes measured in milliliters. As the 
cardiomyocytes have a very limited if not nonexistent potential to proliferate, they need 
to be seeded at very high densities into the constructs to allow the cells to form cell-cell 
connections via gap junctions. This is crucial to the functionality of an engineered 
conductive tissue device.   
Even though the use of microfabrication techniques minimizes the cell number 
needed for the constructs, the number of cells obtained from each isolation is still not 
sufficient. As mentioned before, the rarity of the samples received and the small cell 
quantities obtained creates limitations. As a result, the cell source in not feasible for 
preliminary experiments to establish new techniques. Due to these reasons, the more 
abundant cardiac fibroblasts are used in this thesis. As the focus of the thesis is to 
realize microfabrication techniques of fibrin hydrogels for TE purposes, the techniques 
can be realized and established using other cells and then later proved using 
cardiomyocytes. Also, a very beneficial attribute of using cardiac fibroblasts is that they 
can be amplified in culture to reach a sufficient quantity and continuous supply of cells.  
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4 CELL-LADEN FIBRIN MICROSTRUCTURING 
USING SOFT LITHOGRAPHY 
4.1 Concept 
The soft lithography technique of micromolding in capillaries (MIMIC) is used to 
fabricate microscale fibrin gel constructs. The concept of MIMIC is displayed in figure 
11. Shortly, a master is fabricated to replicate PDMS with the desired channel 
dimensions. The PDMS is then sealed to a cleaned and hydrophilized glass slide after 
which the channels can be filled with fibrin gel. After polymerization, the PDMS is 
peeled off depositing the fibrin lines onto the glass slide. 
 
 
 
Figure 11. Concept for micromolding fibrin gel in capillaries (MIMIC). Picture adapted 
from [35]. 
4.2 Materials and methods 
4.2.1 Self-made master fabrication 
Low-cost wafers are fabricated using tape, a glass slide, and aluminium foil as 
previously explained by Shrirao & Perez-Castillejos [64]. This fabrication technique is 
very simple and the materials needed are basic, inexpensive, and found in almost every 
laboratory. The fabrication process is displayed below in figure 12. 
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Figure 12. Design and fabrication of a simple microstructured PDMS layer: A design 
for the wanted structure is placed under a glass slide (A). Layers of tape are added and 
the structure is cut out according to the design (B & C). Aluminium foil is fixed around 
the glass slide (D) and folded (E) to create walls for the wafer. PDMS is added, cured, 
and peeled off from the wafer, giving rise to the designed microchannel (F). 
 
A design of the desired microstructure is printed out on a piece of paper, positioned 
under the glass slide and fixed with more tape from the corners of the slide (figure 12a). 
Either opaque Scotch tape (Scotch® Magic™ Tape) or transparent Tesa tape (tesafilm® 
transparent) is used to create the structures. Four (Scotch tape) or five (Tesa tape) layers 
of tape are attached to the glass slide (76mmx26mmx1mm, Geputzt / Gebrauchsfertig, 
Engelbrecht Medizin und Labortechnik GmbH). A scalpel is used to cut out the 
designed structure (figure 12b), following the outlines of the layout, and the excess tape 
surrounding the designed pattern is removed (figure 12c). It is then placed into an oven 
at 65°C for three minutes to improve the adhesion of the tape to each other and also to 
the glass. The glass slide is then fixed from the sides with tape to a layer of aluminium 
foil (figure 12d), which was folded from the sides to create walls for the mold (figure 
12e). The mold can then be filled with PDMS, cured in the oven, and peeled off giving 
rise to the PDMS microchannel designed (figure 12f). 
The thickness of the tape will determine the height of the microchannel and can be 
easily altered by changing the number of tape layers. The thickness of the tape was 
measured with a 3D laser-scanning microscope (Violet Laser Scanning Microscope; 
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Keyence VK-9710) in order to determine the thickness of the final microchannel. The 
height was measured to be approximately 50 µm for both tapes, thus the microfluidic 
channels used in this thesis have a height of approximately 200-250 µm. 
4.2.2 PDMS molding 
PDMS (Sylgard® 184 Silicone, Dow Corning) is prepared by mixing the silicone 
elastomer base with the curing agent in a 10:1 ratio by weight. The mixture is let stand 
for a few minutes until most of the air bubbles are cleared and then it is cast into the 
desired mold. Left over air bubbles are carefully punched with a needle (Magellan™ 
Safety Needle, Kendall) and then the PDMS is cured in a heating oven (Binder FD 115) 
at 60°C for approximately one hour. A scalpel is used to cut out the PDMS from the 
side of the wafer wall to release it from the mold. The PDMS is stored in a plastic petri 
dishes (100 mm !) sealed with parafilm in a clean and dry environment until use.  
4.2.3 Surface treatment of PDMS and glass 
The PDMS is treated with oxygen plasma (Plasma Line 415, Tegal Corporation; 160 W, 
160 sccm, 12 seconds) to create a hydrophilic surface that will promote the filling of the 
channels. After plasma treatment, the plastic petri dish is immediately closed and sealed 
with parafilm. The PDMS pieces are covered with 70% ethanol for 30 minutes and then 
rinsed with milliQ™ three times.  
One of the two surfaces, depending on where the fibrin gel lines should be 
deposited, is coated with Pluronic® F-127 (Sigma P-2443) to prevent the adhesion of 
the fibrin gel to the unwanted surface (glass or PDMS). Incubation is done in room 
temperature for approximately two hours. After the Pluronic® coating, the PDMS/glass 
slide is washed three times with milliQ and dried. 
Microscope cover glasses (20 mm !, REF 0111600, Marienfeld) are sterilized at 
200°C for four hours. The glass slides are then cleaned and hydrophilized using 5% 
NaOH (Sigma), rinsed with milliQ™, and finally submerged in 70% ethanol for a few 
seconds and let air-dry.  
4.2.4 Cardiac fibroblast cultivation 
Cardiac fibroblasts are cultured in cell culture flasks using DMEM at 37 °C and 5 % 
CO2. The medium is changed twice a week to remove waste and supply nutrients to the 
cells. When the cells reach confluence, they are either harvested for use in experiments 
or passaged and seeded into new flasks to increase the surface area for the cells. During 
passaging, the medium is first aspirated from the flask and the cells are washed with 7 
ml of PBS, which is followed by incubation with 3 ml of 0.05% Trypsin EDTA (PAA, 
L11-660) for 5 minutes at 37°C and 5% CO2 to detach the cells from the surface. The 
flask is gently hit to help detach all the cells. A double volume of medium is quickly 
added to cancel out the effect of the trypsin before it starts to damage the cells. The cell 
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suspension can then be transferred to e.g. multiple 75 cm2 cell culture flasks or one 175 
cm2 cell culture flask, and later on in 500 cm2 Triple flasks (VWR, 734-2001) 
depending on when cells will be used. 
The same procedure is carried out when cells are harvested from the culture flask to 
be used for experiments. Cells are trypsinized, as explained above, and transferred to a 
50 ml Falcon tube and centrifuged at 200 G for 10 minutes. The supernatant is aspirated 
and the cell pellet is re-suspended in the required volume of Trizma buffered saline 
(TBS: 4l MilliQTM; 4.91 g/l Trizma HCl (Sigma T-3253); 0.72 g/l Trizma Base (Sigma 
T-6066); 9.00 g/l NaCl (Sigma S-9625); 0.23 g/l KCl (Merck 1.04936.0500); pH 
adjusted to 7.40) for fibrin gel fabrication. Cardiac fibroblasts were used for 
experiments at passage 2-5. 
When cells are embedded in fibrin gel and the constructs are further cultivated, 
several supplements are added to the normal cell culture medium. DMEM-based tissue 
culture medium, which is used for cardiac fibroblasts embedded in fibrin gel, consists of 
10 % fetal bovine serum, 1 % antibiotic-antimycotic solution (Gibco, 15240-026), 888 
µg tranexamic acid (Pfizer Cyklokapron®) and 160 mg of L-ascorbic acid (Sigma 
A8960-5G) per 0.5 liters of DMEM. 
4.2.5 Fibrin synthesis 
Lyophilised fibrinogen from human plasma (Calbiochem Cat. #341576) is dissolved in 
purified water (MilliQTM Millipore). After a few hours the solution is transferred into a 
dialysis tubing (Spectrum, Spectra Por No 132655, Pore size 6000 – 8000 MW) for 
dialysis against four liters of TBS overnight. The concentration is determined using a 
photo spectrometer (ThermoSpectronic Genesys 6) at a wavelength of 280 nm using the 
following equation:  
 !!"#$"%&'(% ! !"#$%&'($)!"#!"!!!! ! !"#$%"&'     (2) 
 
 
In this thesis a fibrin gel concentration of 10 mg/ml is used. Fibrin gel consists of 
50% Fibrinogen solution, 35% TBS-cell suspension, 7.5% 50 mM CaCl2 (CaCl2: 735 
mg CaCl2 (Sigma C-3881) in 100 ml TBS) and 7.5% 40 U/ml Thrombin (Sigma T-4648 
in TBS) (see figure 13). TBS-cell suspension, thrombin and CaCl2 are mixed together as 
one component, which is then brought together with the fibrinogen.  
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Figure 13. Components needed for fibrin gel fabrication. 
 
All components can be sterile filtered using a syringe filter (Corning; Part No. 
431219) or TBS and CaCl2 can alternatively be sterilized in an autoclave (Systec 
2540El). The final cell concentration used in experiments was approximately 500 000 
cells per ml of fibrin gel. 
4.2.6 Fibrin micromolding  
Thrombin, TBS, and CaCl2 are mixed together and 20 µl of the solution is put in an 
eppi. In unsterile experiments, food coloring (Schwartau) is used as a visualization aid. 
The same amount of fibrinogen is taken and while the solution is still in pipette, the 
volume of the pipette is set to 30 µl. The fibrinogen solution is carefully released into 
the eppi, the two solutions are quickly mixed, and injected into the microchannel. After 
5 minutes, TBS is carefully added to the entrance and the exit of the channels to ensure 
that the gel does not dry out. The gel is left to further polymerize for about 30 minutes. 
Then the PDMS is carefully peeled off.  
4.2.7 Microscopy 
A light microscope (Axiovert 25, Zeiss) connected with a camera (JVC, KYF75U) is 
used to evaluate cell behavior in the molded fibrin microstructures. A laser-scanning 
microscope was used to determine surface roughness and thickness of the tapes used to 
fabricate wafers for PDMS replication. 
4.3 Results and discussion 
4.3.1 Device fabrication 
A microfluidic device is constructed using microstructured PDMS and a glass slide. The 
two are sealed together to form a channel that can be used as a mold. The technique 
used for the fabrication of the self-made master for the PDMS replication gives a 
simple, fast, and low-cost alternative to the conventional master fabrication using rapid 
prototyping with a photolithography process. The fabrication of a photolithographically 
prepared master is done in a cleanroom, which can be a limiting factor for most 
laboratories. Additionally, the design and fabrication of the master requires sufficient 
1st component  
50 % fibrinogen (20 mg/ml) 
 
 
2nd component 
35% TBS-cell suspension 
7.5% thrombin (40 U/ml ) 
7.5% CaCl2 (50mM) 
Fibrin gel 
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knowledge and skills from the person. The self-made master fabrication technique is 
ideal for preliminary studies where medium size microstructures are needed. The 
accuracy can be further increased and smaller structures can be obtained by using laser 
cutting instead of a scalpel for the cutting. However, fabricating a master from tape and 
a glass slide also has its downsides. As masters are hand-made, every single one is 
unique and thus differs in dimensions from the previous one. Also, the masters have a 
limited lifespan because the lines of tape tend to peel of with the PDMS.  
To prove that the surface treatment of the PDMS with oxygen plasma and Pluronic® 
truly increase the hydrophilicity of the surface; a homemade contact angle measurement 
was done using a camera. The hydrophilicity of the PDMS was evaluated before and 
after surface treatment to see the effect of the surface treatment on the hydrophilicity of 
the surface. Even though proper contact angle measurements were not carried out due to 
lack of equipment, the pictures below (figure 14) clearly display that surface treatment, 
either plain oxygen plasma or both oxygen plasma and Pluronic® coating, truly increase 
the hydrophilicity of the PDMS surface. 
 
     
Figure 14. Hydrophilicity of PDMS: without treatment (A), with oxygen plasma 
treatment (B), and with oxygen plasma treatment and Pluronic® coating (C).  
 
The PDMS can be sealed permanently or temporarily to the glass slide depending on 
the use of the device. In the case of micromolding, the PDMS is sealed temporarily to 
the glass slide so that it can be removed after the polymerization of the gel. If the device 
is used under increased pressure e.g. as a flow chamber, the PDMS should be sealed to 
the glass permanently. A microfluidic device is fabricated and presented in the figure 
below.  
 
   
Figure 15. Filling of a permanently bonded PDMS to glass slide microfluidic device.  
 
A noteworthy characteristic of microfluidic channels is the laminar flow of fluids; 
the velocity at a given spot in the channel is constant in time. This is the reason the two 
adjacent streams of different color liquids are flowing side-by-side in the microfluidic 
device presented below (figure 15) –mixing of the two colors is only by diffusion at the 
interface. [35]  
A B
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As stated in chapter 3, isolating large numbers of cardiomyocytes from the cardiac 
auricle tissue biopsy is challenging. Because of the limited amounts of cardiomyocytes 
that would be available for the micromolding application, it is better to make very 
simple microstructure design for the molding procedure. Also, it is best to exploit the 
capillary filling of the structure with practically the exact volume to fill the channels to 
avoid any dead volume. For example in the device presented in figure 15, there is a lot 
of dead volume that needs to be filled. To prevent this, a master is created with simple 
parallel stripes of tape (approximately 1 mm x 1 cm) and replicated to form channels 
with a height of approximately 250 !m. When cells are used, a single channel is 
replicated into PDMS to even further decrease the amount cells needed. Figure 16 
presents the PDMS channel replicated from the self-made master.   
4.3.2 Optimal tape for master design 
Two different tapes, Scotch and Tesa, were evaluated for use in master fabrication. The 
Scotch tape has a white, matte appearance but when glued on a surface it is transparent. 
The adhesive side is not as sticky as in normal office tape, which is ideal as there are no 
glue residues. During replication, the white surface of the Scotch tape is transferred to 
the PDMS thus resulting in opaque microchannels (figure 16a). This is a great 
disadvantage if the PDMS is to be visualized under the microscope e.g. if cells are 
cultured on microchannels created using this tape.  
The Tesa tape is see-through and results in transparent PDMS microchannels (figure 
16b). This is a great advantage if the PDMS wants to be visualized under the 
microscope. The downside of using office tape is that the adhesive side is stickier 
compared to the Scotch tape and thus at times results in glue residues at the edges of the 
lines of tape These are then of course replicated to the PDMS creating additional 
patterning around the microchannel.  
 
 
Figure 16. Comparison of PDMS replicated from a master made with opaque Scotch 
tape (A) and with transparent Tesa tape (B). 
 
As the surface properties play a significant role in microfluidics, the surface of the 
tape used for the master fabrication is evaluated. A strip of tape (both Scotch and Tesa) 
was sealed to a glass slide and the surface roughness was measured using a laser-
scanning microscope. The figure below presents the area of measurement (highlighted 
A B 
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in blue). As it can be seen from the figure without any other measurement data, the 
Scotch tape (figure 17a) appears to have much higher surface roughness compared to 
the Tesa tape (figure 17b).  
 
  
Figure 17. Surface roughness analysis of Scotch (A) and Tesa (B) tape. The blue square 
represents the area of measurement (tape).  
 
From the measurement data, the arithmetical mean roughness (Ra) values of the two 
tapes were compared. The Ra is the arithmetical mean of all the sums of all profile 
values. The Ra for the Scotch tape was 1.599 µm and for the Tesa tape 0.226 µm, which 
demonstrates that the surface roughness of the Scotch tape was much higher than that of 
the Tesa tape. 
In the end, both tapes had its advantages and disadvantages. In this thesis, Tesa tape 
was used for applications where the transfer of the fibrin was done onto the PDMS. This 
is because the Tesa tape is transparent, so the cells embedded in the fibrin could be 
visualized with the microscope. On the other hand, Scotch tape was used for 
applications where the PDMS was used just as a temporary molding device. In this case, 
the surface properties in terms of visualization did not matter. 
4.3.3 Proof of principle 
The first experiments are done without cells to demonstrate that the concept designed is 
feasible. The microstructured PDMS and the glass slide are sealed together to create 
microchannels and filled as previously explained. Blue food coloring is used as a 
visualization aid and it is dissolved into the TBS before it is mixed with the other 
components. 
The filling of the channels needs to be done very quickly so that the gel does not 
polymerize before it has a chance to fill the channel completely. If the mixing in the 
eppi takes too long, the fibrin gel can already be too polymerized and will not even 
enter into the channels. This is the most crucial phase of the entire micromolding 
process. 
As the PDMS and the glass slide are both made hydrophilic, the fibrinogen solution 
fills the channels very easily. The unpolymerized fibrin gel mixture is introduced to the 
A B 
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entrance of the channel, and due to capillary forces it fills the channel (see figure 18). 
No external pressure is needed.  
 
    
Figure 18. The filling of the channel by capillary forces. Time represented in seconds.  
 
After 5 minutes, TBS is carefully added to the entrance and the exit of the channels 
to ensure that the gel does not dry out. The gel is left to further polymerize for about 30 
minutes. Then the PDMS is carefully peeled off. The micromolded lines of fibrin gel are 
deposited on either the glass (figure 19a) or the PDMS (figure 19b) depending on which 
surface is coated with Pluronic®.  
 
  
Figure 19. Micromolding of fibrin in capillaries. A: PDMS is coated with Pluronic® 
thus the deposition of fibrin gel is on the glass. B: Glass slide is coated with Pluronic® 
thus the fibrin gel stays in the PDMS.  
 
Two fibrin gel concentrations were compared to find the optimal one for use in 
micromolding. In the group the standard fibrin gel concentration used is 5 mg/ml of gel. 
This was attempted in the first trials but resulted in a very watery gel (see figure 20).  
 
 
Figure 20. Comparison of fibrin gel concentration: 5 mg/ml (top) and 10 mg/ml 
(bottom).  
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It seemed that the gel did not polymerize properly in such a small, confined space. A 
double concentration was tested and it resulted in a stiffer, stronger, and less watery gel. 
The gel structure was much easier to handle and it could even be peeled off from the 
glass slide completely intact. A downside of using the higher fibrin gel concentration is 
that it polymerizes quicker and thus the filling of the channels needs to be done swiftly. 
4.3.4 Micromolding cell-laden fibrin gels 
After demonstrating the concept of micromolding fibrin in capillaries is functional, cells 
are incorporated into the molding process. The behavior of the cells in the confined 
geometry is evaluated using phase contrast microscopy. Both deposition of fibrin onto 
PDMS and onto glass are displayed.  
The 10 mg/ml fibrin gel supported proliferation of the cardiac fibroblasts and cells 
were distributed homogenously within the gel during the molding process. Figure 21 
displays the deposition of fibrin gel with cells onto glass using MIMIC. The cells 
aligned in the longitudinal direction. The diameter of the microchannel used to mold the 
fibrin gel seemed to have an effect on the degree of orientation of the cells. As the width 
of the channel decreased, higher cell alignment was observed (figure 21b, 21d and 21f). 
As a downside, when cells proliferated they started migrating out of the fibrin and 
started growing is 2D on the glass. In the future, this could be possibly prevented by e.g. 
coating the glass with a cell-repellent.  
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Figure 21. Fibrin gel with embedded cardiac fibroblasts (passage 2) molded using 
MIMIC technique onto glass. A & B: Day 3, C & D: Day 6, E & F: Day 12. Scale 500 
µm.  
 
Overall, cell behavior between different batches was observed. This could be 
affected by the age and also the type of cardiac disorder the patient had. The cells 
behaved differently already in culture as some cells did not grow at all.  
When observing the arrangement of the cells in different depths of the molded 
fibrin, cells demonstrated alignment mainly at the top of the 3D gel line, not at the 
bottom. The figure below (figure 22) presents the different alignment properties of the 
cells at different depths in the 3D gel. When focusing near the glass slide, the cells 
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appear to be randomly oriented with very little longitudinal orientation (figure 22a). On 
the other hand, when focusing to the top of the gel near the surface, alignment of cells 
can be seem (figure 22b). This could be due to different surface properties of the glass 
and the PDMS. As previously explained, the surface of the Scotch tape used to fabricate 
the channels is rather rough which replicates to the roof of the PDMS microchannel. 
This means the top and the bottom surfaces of the microchannel possess different 
surface properties. When the channel is filled with fibrin, the different surface properties 
can effect the polymerization of the fibrin gel. This could then reflect straight on the cell 
behavior.  
 
  
Figure 22. Fibrin gel with embedded cardiac fibroblasts (passage 5) molded using 
MIMIC technique onto glass. Focus is set near the glass surface (A) and at the top near 
the surface of the fibrin line (B). Pictures taken after approximately one month of 
culture. Scale 500 µm. 
 
Figure 23 demonstrates the deposition of fibrin gel with cells onto PDMS using 
MIMIC. As the cells proliferated, they started to migrate out of the fibrin gel embedded 
in the PDMS grooves. This shows that the PDMS surface is appealing to the cells as 
they also grow there. As mentioned before, using a cell-repellent coating on the PDMS 
interspaces could possibly prevent this. The cells did not demonstrate alignment in the 
construct. The width of the channels used was probably too big, thus the use of smaller 
channels could create higher cell alignment. 
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Figure 23. Fibrin gel with embedded cardiac fibroblasts (passage 3) molded using 
MIMIC technique onto PDMS. A. Day 1; B. Day 5; C. Day 8; D. Day 10. Scale 500 µm. 
 
The manipulation of one molding surface with Pluronic® provides the freedom to 
decide on which surface the deposition of the gel is wanted. This creates different 
possibilities of how the fibrin lines can be used, for example how they can be 
incorporated into a larger scale construct for TE applications. If the molded lines of 
fibrin are to be used as separate units and need to be peeled off from the mold, the 
deposition of the fibrin gel needs to done on glass. This way, the fibrin lines can be 
peeled off without damaging them. This cannot be done from the PDMS substrate as the 
adhesion of the gel is too tight and the fibrin line breaks fairly easily. As an example, 
the peeled off fibrin lines can be incorporated into a thin layer of additional fibrin gel 
which can then be manipulated e.g. by rolling to form a final tissue construct. 
Alternatively, additional fibrin gel can be added on top of the microfabricated lines on 
the glass or on PDMS to embed the lines into more fibrin gel. The microfabricated 
fibrin lines and the additional layer can be encapsulated with different cell types to 
allow the fabrication of a construct with several cell types in an organized manner.   
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5 MICROFABRICATION OF FIBRIN FIBERS 
5.1 Concept  
Fibrin hydrogel microfibers are fabricated by coextruding the two liquid solutions, 
fibrinogen and thrombin, through small diameter tubing. A syringe pump is used to set a 
continuous flow in the system. The idea is to extrude microscale tubular hydrogel fibers 
that can be applied in TE applications. This fibrin extrusion concept was demonstrated 
previously by Cornwell et al. in 2006. [61] In this thesis, the same principle is applied 
but with alterations. Endothelial cells (ECs) are incorporated into the molding process to 
fabricate fibers with spatially patterned cells that could be further used as preformed 
vascularization modules and possibly incorporated into larger scale tissue constructs. 
The concept is presented in the schematic below (figure 24). 
 
 
Figure 24. A schematic drawing of the concept used to extrude fibrin fibers.  
5.2 Materials and methods 
5.2.1 Endothelial cell cultivation 
Human vein endothelial cells, a kind gift from a colleague, are cultured in 75 cm2 cell 
culture flasks using Endothelial Cell (EC) Growth Medium (Basal medium C-22010; 
Supplements C-39215, PromoCell). The flasks are first coated with 0.02% Gelatin 
(Bovine Skin, Type B, Sigma G-9391 in MilliQ) for cell adherence. Gelatin is steam 
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sterilized in the autoclave, aliquoted and stored at 4°C. Upon use, it is heated to 37°C 
and each flask is filled with 5 ml while the excess is aspirated. The flasks are let dry 
under the laminar flow bench for approximately one hour before cell seeding.  
The cells are cultured in an incubator at 37°C and 5% CO2. The culture medium is 
changed twice a week. Upon confluence, the cells are passaged as described for cardiac 
fibroblasts in chapter 4.2.4 and re-seeded into gelatin-coated 175 cm2 cell culture flasks. 
Cell harvesting is done as also described for cardiac fibroblasts with the exception that 
the cells are centrifuged at 500 G for 5 minutes. Endothelial cells were used for 
experiments at passage five. 
When cells are embedded in fibrin gel and the constructs are further cultivated, 
several supplements are added to the normal cell culture medium. The EC-medium is 
supplemented with 1 % antibiotic-antimycotic solution and 888 µg tranexamic acid per 
0.5 liters of medium.  
5.2.2 Fibrin synthesis 
Fibrin gel synthesis is done as described previously in chapter 4.2.5. The final cell 
concentration used in experiments was approximately 2.5 million cells per ml of fibrin 
gel.  
5.2.3 Fibrin fiber extrusion 
Fibrin fibers are extruded into a glass petri dish filled with either TBS or EC culture 
medium using a syringe pump (Perfusor® Compact S, Braun). Two syringes (Injekt-F / 
Omnifix®-F 1 ml, Braun) containing the fibrinogen solution and the thrombin solution 
are fixed to a DUPLOJECT double syringe holder (Tisseel, Baxter) and the syringes are 
connected together with a dual-lumen spray head, which upon coextrusion combines the 
two solutions together and ensures profound mixing at the tip. The tip of a 50 ml 
syringe (Original-Perfusor® Syringe, Braun) is cut off and the entire DUPLOJECT 
system is then assembled and fixed tightly inside it by using surgical tape and the 
solutions are coextruded through perfusor line tubing (Original Perfusor® Line 50 cm, 
Braun) with an inner diameter of 1 mm. Both the syringe holder and the spray head can 
be sterilized in an autoclave.  
The perfusor line is attached to the spray head and the line cut to a length of about 
25 cm. In unsterile experiments, food coloring (Schwartau) is used as visualization aids. 
On the other hand, in sterile conditions an LED-light is used to aid visualization, which 
can be sterilized by hydrogen peroxide (H2O2) plasma. 
5.2.4 Immunohistochemistry 
The immunohistochemical staining procedure for the two-photon microscopy is 
explained here shortly. The tissue piece is fixed with -20°C methanol for 30 minutes at 
room temperature. Then, the sample is washed with PBS consisting 1% gentamycin and 
0,32% tranexamic acid over night. After that, the sample was incubated with 4',6-
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diamidino-2-phenylindole (DAPI, Sigma D-9564) to mark the cell nuclei for 30 
minutes. The sample is stored in PBS consisting 1% gentamycin and 0,32% tranexamic 
acid at 4°C.  
5.2.5 Microscopy 
A two-photon microscope is used to evaluate cell orientation in the 3D fibrin fibers 
produced. For image acquisition the two-photon laser scanning microscope (TPLSM) of 
the IZKF Aachen was used consisting of an Olympus FluoView 1000MPE with a 25x 
water objective NA1.05 (Tokyo, Japan), a mode-locked MaiTai DeepSee Titanium-
Sapphire Laser (Spectra-Physics, Stahnsdorf, Germany) and the acquisition software 
FluoView FV 10 2.0. 
Scanning electron microscopy (SEM) is used to evaluate fiber alignment of the 
microfabricated fibrin fibers. The preparation of the fibrin gel samples for scanning 
electron microscopy (SEM) was done at the University Hospital Aachen 
(Elektronenmikroskopische Einrichtung (EME)). Shortly, samples were fixed by 
immersion in 2.5% glutaraldehyde in 0.1M Sorenson’s buffer (pH 7.4) for 12 h. 
Dehydration was done in rising acetone concentrations. The samples were then dried 
using critical point drying (E-300 Critical Point dryer; Polaron Equipment, Watford, 
United Kingdom). The samples were transported in a vacuum desiccator to the Institut 
für Textiltechnik (ITA) at RWTH Aachen for gold-palladium spattering and imaging. 
The images were acquired at 15 kV.   
5.3 Results and discussion 
5.3.1 Proof of principle 
The first experiments are done without cells to demonstrate that the concept designed is 
feasible. The complete procedure is executed in a way that is then reproducible under 
sterile conditions. Thrombin, TBS, and CaCl2 are mixed together in a 24-well plate and 
0.5 mL is filled into a syringe. An equal amount of fibrinogen is placed in another 
syringe and both syringes are fastened into a double-syringe holder (figure 25a). 
Removal of air bubbles from the syringes is extremely important as this can result in 
holes or even complete gaps in the fibers. The syringes are connected to the syringe 
pump (figure 25b) as explained in the previous chapter. By using a syringe pump, the 
entrance of the components into the tubing occurs simultaneously and also the formed 
fiber is pushed out continuously, which minimizes blockage at the exit. It is crucial that 
the double syringe holder is placed very tightly, exactly in the middle of the larger 
syringe to ensure continuous flow and even distribution of solutions from both syringes.  
A LED-light source is placed around the glass petri dish to allow better visualization 
of the formed fiber. Also, blue food coloring, which is dissolved in TBS, is used as a 
visualization aid. 
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Figure 25. Components used for fiber extrusion. 
 
The syringe pump is set to 200 ml/hour (3.33 ml/min). The priming of the tubing 
takes about 1-2 minutes. The fiber formed at a rate on 3.93 mm/s. The tubing is slowly 
dragged by hand vertically at the bottom of the glass petri dish through the bath as the 
fiber started to form. The dragging of the tubing tip is done at approximately the same 
rate as the polymerizing fibrin moves in the tubing. This eased the exit of the fiber into 
the bath as it had a surface to attach to. Also, the movement on the tip of the tubing is 
crucial to the outflow of the fiber so that it would not form clumps.  
The length of the tubing and the speed of the pump were adjusted so that the fiber 
was polymerized as it exited the tubing. Fibers were left in the bath for further 
crosslinking for approximately 10-15 minutes. Then they were carefully detached from 
the bottom of the petri dish with tweezers and placed in a smaller petri dish with TBS.  
The resulted fibers are displayed in figure 26a in a petri dish. The diameter of the 
formed fibers in TBS was evaluated using light microscopy. As the dragging of the 
tubing during fiber processing was done by hand, the speed was not consistent and thus 
resulted at times to non-uniform fibers. If the tip was pulled too fast, the fiber stretched 
and became thinner. Other the other hand, if the dragging of the tip was too slow the 
fibrin would start to collect together and form a bundle. At most parts of the formed 
fiber, the diameter was measured to be about 1 mm (see figure 26b), which is equal to 
the inner diameter of the tubing. 
 
A B 
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Figure 26. A. Extruded fibrin fibers in a plastic petri dish using (100 µm !) B. Light 
microscope picture of an extruded fibrin fiber, with a diameter of approximately 1 mm, 
in TBS.  
 
In an attempt to create smaller diameter fibers, a pipette tip (TipOne® 200 µl, 
Starlab) is attached to the end of the tubing as displayed in figure 27a. This resulted in 
fibers with a diameter of approximately 400-500 µm (see figure 27b). The fabrication 
was more difficult compared the larger diameter fibers mainly due to the small size. 
Also, the fibers were much weaker and more difficult to handle. Additionally, the tip 
was difficult to secure tightly onto the tubing, which caused some leakage. 
 
  
Figure 27. A. A pipette tip (200 µl) was added to the end of the tubing to allow 
fabrication of smaller diameter fibers. B. Light microscope picture of an extruded fibrin 
fiber, with a diameter of approximately 400-500 µm, in TBS. 
 
The effect of flow on fibrin fiber alignment during extrusion was analyzed by SEM. 
The image below (figure 28) indicates that flow during polymerization of the gel 
increases the orientation of the fibers in the direction of the extrusion. This could be 
advantageous for applications where cells want to be aligned in 3D hydrogel constructs.  
 
A B 
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Figure 28. SEM image of an extruded fibrin fiber with the direction of the flow being 
indicated by the arrow.  
5.3.2 Extrusion of cell-laden fibrin fibers 
After proving the concept of fibrin fiber extrusion is functional, cells are incorporated 
into the molding process. Instead of using a TBS bath, the fibers are extruded into a bath 
of EC medium. This way the time that the cells are left without nutrients is minimized. 
The length of a single fiber was intentionally kept under 4 cm to prevent tangling of the 
fiber during moving of the well plate e.g. to the incubator. The forming fiber was cut 
using a small spatula upon extrusion at the tip of the tubing. After polymerization, the 
fibers are carefully transferred into a 6-well plate with fresh EC medium and placed in 
an incubator for further cultivation. The fibers were cultivated for 8 days and the 
behavior of the cells was evaluated by light microscopy.  
The distribution of cells in the formed gel was homogeneous in the fibers formed at 
the beginning of the extrusion process. Towards the end, the cell number decreased as 
the cells started to clot in the syringe. This indicates that the entire extrusion process 
needs to be executed quickly while the cells are still evenly distributed in the solution. 
The fibrin gel concentration of 10 mg/ml was shown to support EC proliferation and 
migration. Over time, the endothelial cells appeared to coalesce and bundle the 
surrounding fibrin into a core around which they arranged themselves. This resembles 
the process of tubulogenesis, the early development of vascularization, in which 
individual cells connect to form a loose network and further organize into multicellular 
cords by subsequent lumen formation. The phenomenon is consistent with previous data 
demonstrating that ECs organize into tubes by bundling the collagen into the core and 
forming a cylinder around it. [51] Raghavan et al. used this idea to create constructs of 
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endothelial tubules by micromolding collagen gel with endothelial cells in 
microchannels using soft lithography. As discussed by the authors, the presence of 
collagen within the lumen of the endothelial tubule is potentially a limitation due to the 
fact that the collagen will not disappear by degradation. The use of fibrin gel is more 
advantageous as it will over time degrade and thus could have the potential to create an 
open lumen for the fibers.  
This tubulogenesis phenomenon can be observed in microscope pictures taken of the 
extruded fibrin fibers. The cells appear to migrate to the surface of the fiber (see figure 
29) to form a monolayer of cells, which is consistent with the behavior of these cells in 
nature. On day one, the cells are embedded within the matrix (figure 29a). With time, 
they appear to coalesce and arrange themselves around the fiber by bundling the fibrin 
into the core of the fiber as the cells form a cylinder around it. On day 4 (figure 29b), 
some cells can be seen at the surface (at the edges) of the fiber. By day 6, the cells have 
almost all the cells have migrated to the surface. In figure 29c and 29d, which are taken 
on day 8, the focus is set the bottom surface of the 3D fiber.  
 
  
  
Figure 29. Tubulogenesis of endothelial cells in fibrin fibers. On day 2 (A), cells are 
embedded homogenously inside the fibrin matrix. On day 4 (B), some cells have 
migrated to the surface and by day 6 almost all the cells are at the surface. Scale bar 
500 µm.  Pictures C and D are taken on day 8 from the lower surface at two planes of 
focus at a short distance to prove that the whole surface was covered. Scale bar 200 
µm.  
A B 
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As the 2D pictures taken with the phase contrast microscope cannot give a full 
evaluation of the position of the cells in 3D space, the nuclei of the cells are stained with 
a fluorescent dye (DAPI) and visualized using a two-photon microscope to confirm the 
results obtained from the phase contrast microscopy pictures. Figure 30 below 
demonstrates the pictures obtained by the two-photon microscope, which clearly 
confirms that the cells have migrated to the surface of the fibrin fiber and are arranged 
in a tubular orientation around the core. 
 
 
 
Figure 30. Two-photon microscopy pictures of fibrin fibers embedded with endothelial 
cells with cell nuclei displayed in blue: top figure presents the top surface of the fiber as 
the bottom figure shows the side view with cells deposited on the surface of the fiber. 
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The technique of coextruding fibrin fibers has been previously published and 
patented by Cornwell et al. [61,65] In this thesis, as a difference to the methods used by 
Cornwell et al., cells were extruded with the fibrin gel components to homogeneously 
embed the cells within the fibers as opposed to seeding them on the surface. Thus in this 
thesis, a novel fabrication process to create cell encapsulated fibrin gel fibers is 
presented. In addition, Cornwell et al. used more than a three-fold higher concentration 
of fibrin gel to fabricate smaller diameter fibers of high mechanical strengths. Most 
likely, this high concentration would not support cell proliferation and migration of cells 
embedded within the fibrin matrix. On the other hand, stiffer gel fibers are much easier 
to handle which is beneficial for e.g. collecting the fibers.  
The hydrogel extrusion technique presented can be applied in many ways in TE 
applications. The endothelial cell-laden fibrin fibers can be used to form functional 
patterned vascular network within a tissue-engineered construct. Alternatively, other 
cell types can also be used for molding microscale tubular tissue constructs. The 
extrusion technique is a way to fabricate long, thin tissue constructs with a degree of 
orientation. As demonstrated in chapter 5.3.1, polymerization under flow increases 
fibrin fiber alignment, which has been demonstrated previously by several groups 
[60,66]. This nanoscale alignment of fibers the fibers in the gel can also guide cells to 
orient in the same direction, and thus create highly aligned 3D tubular tissue constructs. 
[60]  
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6 BOTTOM-UP TISSUE ENGINEERING OF A 
CARDIAC CONDUCTIVE DEVICE 
6.1 Concept 
Microfabrication of small, biologically relevant size structures with controllable shape 
and combining them together is a promising approach to create complex, highly 
organized tissue constructs. In this thesis two techniques for fibrin micromolding are 
presented with the intention to provide a highly controllable three-dimensional 
environment that can mediate cell differentiation and functional assembly.  
The micromolded tissue constructs demonstrated in this thesis could be used as 
functional tissue units and further assembled in a larger scale tissue construct using the 
strategies of bottom-up tissue engineering. Many tissues, e.g. cardiac tissue, are 
constructed of several cell types that form functional tissue units that are further 
assembled together to create the complex tissue formation. For example, cardiac tissue 
is made up of tightly packed aligned myofibrils with dense supporting vasculature and 
ECM. Even though cardiomyocytes are the major functional component, the supporting 
role of fibroblasts and endothelial cells is vital. Especially without sufficient 
vasculature, the energy consuming cardiomyocytes are deprived of oxygen and other 
nutrients. These components (cardiac myofibrils, supporting ECM, and capillary 
network) could be fabricated as separate tissue units using the microfabrication 
techniques presented and later combined to create a construct with all the valuable 
building blocks.  
As previously described, the MIMIC technique could be used to orient 
cardiomyocytes longitudinally in 3D fibrin gel constructs to allow the cells to form gap 
junctions with each other to form a functional syncytium that would allow the 
conduction of the electrical impulses. The extruded fibrin fibers with endothelial cells 
could be applied to preform the vascularization to provide sufficient nutrition to the 
cells, especially to the cardiomyocytes, which cannot tolerate hypoxia for long time 
periods. The third missing component of the cardiac tissue is the ECM. Fibroblasts 
produce the ECM, which provides the mechanical support for the tissue.  
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Figure 31. Schematic of the bottom-up tissue engineering approach for the Biopacer.  
 
The idea of using bottom-up TE for the fabrication of a conductive tissue device is 
displayed in figure 31. The idea is to fabricate a thin layer of fibrin gel with fibroblasts 
encapsulated homogenously inside. Before it fully polymerizes, the other two building 
blocks, the fibers with endothelial cells and the aligned cardiomyocyte lines, are 
assembled in the desired orientation into the thin layer. After polymerization, this thin 
layer could be rolled tightly enclosing the added components within the construct giving 
rise to a TE conductive tissue device fabricated using the bottom-up TE approach 
containing all cellular components. 
6.2 Proof of principle 
A proof of principle of how the micromolded tissue constructs fabricated in this thesis 
could be assembled together to form a conductive tissue device is presented in this 
chapter. The demonstration is done unsterile using food coloring as a visualization aid. 
Cardiomyocytes could be molded into fibrin gel lines using MIMIC (figure 32a). These 
lines could be further cultured to allow formation of cell-cell junctions and the guided 
organization of the cells in the longitudinal direction. These lines can then be embedded 
into a thin layer of fibrin gel (figure 32b), which can be rolled (figure 32c), in this case 
with a suture line, to create an organized tubular large-scale 3D tissue construct (figure 
32d). Supportive cells, e.g. fibroblasts, can be incorporated into the thin fibrin layer, 
which could eventually start to form ECM around the aligned cardiomyocyte lines.  
 
 
 
 
Extrusion of fibrin fibres  
with endothelial cells 
Roll structure into a 
tubular construct 
Cardiomyocyte embedded fibrin  
lines fabricated using MIMIC 
Thin layer of fibrin gel  
embedded with fibroblasts 
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Figure 32. The fabrication of a 3D tubular tissue construct by using a bottom-up TE 
approach with micromolded fibrin tissue units as building blocks.  
 
Additionally, extruded tubular fibers of fibrin gel with endothelial cells could be 
incorporated into the construct in the same way. These fibers could be embedded 
randomly along with the strings of cardiomyocytes fabricated using MIMIC in the thin 
fibrin layer before rolling the complete construct into a tubular 3D structure with the 
idea that the fibers would provide a preformed basis for the vasculature. Additional 
sprouting of the endothelial cells away from the fibers could possibly accommodate for 
further capillary formation. By preforming the structural outline for capillary formation, 
it could induce vascular development and thus tackle with the problem of the inability to 
vascularize tissue constructs that exceed the diffusion limits of oxygen and nutrients.  
 
 
 
 
 
 
 
 
 
A B 
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7 CONCLUSION 
Applying microfabrication techniques to create hydrogel constructs with controlled 3D 
arrangement of cells can provide a way to mimic the high-degree organization of native 
tissues. Microfabrication techniques can be used to create functional tissue modules to 
use as building blocks to engineer larger scale 3D tissue constructs. This way a spatially 
organized, native-like tissue microarchitecture could be created. 
In this thesis, two microfabrication techniques were established and exploited for 
engineering a biological pacemaker –a conductive tissue device. The techniques were 
realized with the use of fibrin gel and human cells. The proof of principle for molding 
fibrin gel in capillaries (MIMIC) using PDMS replicated from a self-made wafer was 
demonstrated. By coating one surface (glass or PDMS) of the closed mold with a 
protein-repellent (Pluronic®), fibrin gel deposition could be selectively carried out onto 
either surface. Longitudinal orientation of cells was observed in small diameter fibrin 
gel lines, demonstrating that the technique can be used to engineering aligned tissue 
constructs in microscale. Due to the difficulties of obtaining sufficient quantities of 
cardiomyocytes for the experiments, the MIMIC technique was realized in this thesis 
using an alternative cell type. Eventually, after further developing the cell isolation 
procedure to obtain higher quantities of cardiomyocytes, the technique can be realized 
also using cardiomyocytes. 
Additionally, a novel technique for extruding viable fibrin fibers for use in TE was 
established. Endothelial cells were incorporated into the process to demonstrate a 
technique for extruding cells homogenously within the hydrogel fibers. SEM images 
taken of the fibers indicated that polymerization of the gel under laminar flow induced 
the alignment of the fibrin fibers. The endothelial cells extruded within the fibers were 
shown to coalesce and bundle the surrounding fibrin into a core around which they 
arranged themselves resembling the process of tubulogenesis, the early development of 
vascularization.  
Overall, the techniques presented in this thesis demonstrate two prosperous methods 
for engineering spatially organized tissue constructs in microscale for TE applications. 
The possibility of using these microfabricated fibrin gel tissue modules as building 
blocks to create a conductive tissue device using bottom-up tissue engineering was also 
described. This way the functional units of the tissue, including highly organized 
cardiomyocytes, vasculature and ECM, could be engineered separately and later 
assembled together to give rise to a construct of high cellular complexity and organized 
tissue microarchitecture. All in all, the techniques established and realized in this thesis 
are not solely applicable for engineering a conductive tissue device but can also be 
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transferred into other TE applications. In the future, the techniques should be further 
developed to fabricate even smaller microscale tissue structures to better mimic the 
native microarchitecture of complex tissues. Additionally, the handling of the 
micromolded hydrogel structures and especially the process of assembling the tissue 
building blocks together require further improvements. 
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APPENDIX 1: BUFFERS USED FOR CELL ISOLATION 
 
 
Calcium-free Krebs buffer (KRP) 
 
Name of chemical Chemical formula Amount per 1,5 Liter  
milliQ  
KRP basic buffer 
Sodium chloride NaCl 3,0681 g 
Potassium chloride KCl 0,5312 g 
Potassium dihydrogen 
phosphate 
KH2PO4 0,2430 g 
Monosodium phosphate NaH2PO4 2,8800 g 
Sodium bicarbonate NaHCO3 3,1504 g 
D-Glucose C6H12O6 2,7024 g 
Saccharose C12H22O11 68,8023 g 
(4-(2-hydroxyethyl)-1-
piperazineethanesulfonic 
acid) (HEPES) 
C8H18N2O4S 5,7193 g 
 
 
Calcium-free Krebs buffer (KRP) + 2,3-Butanedione monoxime (KRP+BDM) 
 
KRP+BDM  
2,3-Butanedione monoxime 
(BDM) 
C4H7NO2 4,5500 g 
 
 
1. The chemicals are dissolved into 1.5 liters of purified water (MilliQTM Millipore)  
2. The pH is set to 7.4.  
3. The buffer is sterilized using a sterile filter (Steritop™ Filter Unit) and stored at room 
temperature. 
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